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The development and awareness of Machine Learning and “big data” has led to a growing interest
in applying these methods to bioanalytical research. Methods such as Mass Spectrometry (MS), and Nuclear
Magnetic Resonance (NMR) can now obtain tens of thousands to millions of data points from a single
sample, due to fundamental instrumental advances and ever-increasing resolution. Simple pairwise
comparisons on datasets of this magnitude can obfuscate more complex underlying trends, and does a
disservice to the richness of information contained within. This necessitates the need for multivariate
approaches that can more fully take advantage of the complexity of these datasets.
Performing these multivariate analyses takes high degree of expertise, requiring knowledge of such
disparate areas as chemistry, physics, mathematics, statistics, software development and signal processing.
As a result, this barrier to entry prevents many investigators from fully utilizing all the tools available to
them, instead relying on a mix of commercial and free software, chained together with in-house developed
solutions just to perform a single analysis. While there are numerous methods in published literature for
statistical analysis of these larger datasets, most are still confined to the realm of theory due to them not
being implemented into publicly available software for the research community.
This dissertation outlines the development of routines for handling LC-MS data with freely
available tools, including the Octave programming language. This presents, in combination with our
previously developed software MVAPACK, a unified platform for metabolomics data analysis that will
encourage the wider adoption of multi-instrument investigations and multiblock statistical analyses.
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Chapter 1: Metabolomics: An Ideal Approach?

1.1 Introduction
Metabolomics is one of the most rapidly growing fields in biological research. Considered
downstream from genomics, transcriptomics and proteomics, it forms the base of the “omics” disciplines,
its goal is to form a complete analysis of the total set of metabolites with in a living system. As the
metabolism of an organism should directly reflect directly observed phenotypes, it has invaluable
applications in biomarker discovery1, toxicology2 and functional determination of genes and their protein
products3. Despite all of this success, metabolomics still suffers from a systemic lack of standardization in
protocols. The sheer variety of instrumentation, data processing modalities and statistical modeling
algorithms results in a wide variety of approaches in the literature, often with little attention paid to which
combination is most effective for a given problem.
Nuclear Magnetic Resonance (NMR) and Mass Spectrometry (MS) are the most widely used
instruments in metabolomics, and there is a growing awareness that the two methods offer synergistic
effects when combined with one another4–6. As a result, it has become clear that the best results are
obtained when both methods are used together so as to minimize the other’s particular disadvantages.
Often times, the practical limitation to performing these integrated studies are not acquisition but analysis.
In NMR, a number of software packages including BATMAN7, Bayesil8, and TOCCATA9 and
databases such as HMDB, BMRB and Chemspider are all routinely used with varying degrees of success.
Packages such as BATMAN require an intimate knowledge of the R programming language in order to
use properly, whereas TOCCATA and Bayesil require little to no knowledge of programming
environments and be used through a simple web interface. There is a price to this convenience
unfortunately, as these online methods are not easily modified or reproduced, and lack any transparency
in this “black box” approach. The aforementioned databases are also not without their shortcomings, often
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failing to have entries for all possible metabolites that could be encountered in a typical study. Some, such
as the HMDB aim to correct this by accepting spectra acquired by the scientific community at large,
which creates a more complete database but leads to a heterogeneity in sample preparation, solvents
utilized and spectral acquisition parameters. MS has a similar variety of tools, including XCMS,
MZMine, and MetAlign among others. MZMine for example, is a largely visual data processing tool,
with required ranges and parameters being user-determined based on observed spectral properties and is
easy to use for anyone with MS background. XCMS however, is much more programmatically driven and
offers a steeper learning curve, but offers powerful automation tools and flexibility unavailable in other
software suites. The needs of which software to use, as in any field is a tradeoff between the time
necessary to devote to learning the tool and what the benefits are of its unique approach.
Both the fields of NMR and MS have independently generated their own solutions for data
analysis, but little attention has been given to platform-independent variants. As a result, no single
software package offers all of the required tools for metabolomics. This often forces researchers to make
use of multiple software packages, utilizing the 1-2 critical functions it provides as part of a larger
processing scheme. The burdensome nature of using these multiple packages presents a tremendous
barrier to entry, in order to learn how to use each of the packages in an appropriate way. Additionally, this
brings even larger concerns of reproducibility; how do we reproduce our results if one of the crucial
pieces is updated and no longer compatible with the rest of the pipeline?
The standards that the field of metabolomics demands, uniformity of process, clarity in
communicating protocols, reproducibility and comparative benchmarking are stifled by the lack of a
single software package to perform all of the necessary steps. For NMR, this need has been met by
MVAPACK, which provides a complete set of functions for each of the necessary steps in NMR
metabolomics data analysis in an intuitive and easy to use platform. As MVAPACK is an open-source
tool, it is extremely transparent in its approach and additional functionality can be added as more
advantageous approaches are discovered. While this consolidation of NMR data processing in the context
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of metabolomics has already taken place, a similar solution has yet to be demonstrated for MS-based
investigations. With the addition of functions for processing MS data within MVAPACK, a single
software package is created that is capable of handling data regardless of which instrumentation is used,
laying the necessary groundwork for future studies that combine both NMR and MS without the need for
self-developed processing pipelines utilizing numerous unrelated software packages.

1.2 Summary of Work
This thesis will attempt to summarize the field of metabolomics, with a focus on the issues
pertaining to data analysis.
Chapter 2 will introduce the field of metabolomics. Typical use cases, and a general overview of
what a metabolomics experiment entails will be presented, along with an exhaustive summary of
algorithms that have been applied towards understanding of the data these experiments generate. A few
technical advances, primarily from the field of NMR and biomarker discovery, and their potential effects
on the field are discussed.
Chapter 3 primarily highlights the burden of choice that is often encountered when processing
metabolomics data. It uses a single step in data processing, normalization, and discusses the myriad of
issues that can arise from this choice. A number of widely used algorithms are compared to their best-inclass counterparts, on both simulated and real NMR datasets to illustrate how relative signal intensity,
noise and overall variance can drastically inform which methods are most appropriate, and perhaps more
importantly, detrimental to accurate results.
Chapter 4 will present a demonstrable workflow for processing LC-MS data, using open-source
software tools that will run on a typical user workstation. The major hurdles that arise from this process,
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as well as some possible techniques to address these limitations are discussed, as well as the potential
benefits to investigators familiar with NMR that are looking to incorporate MS and vice-versa.
Chapter 5 concludes the thesis, with a few parting thoughts on the state of the field as well as
presenting natural extensions to the research described herein. Potential directions of both software
development and methodology and their ability to address some of the next logical steps in metabolomics
are entertained.

References

1.

Kind, T., Tolstikov, V., Fiehn, O. & Weiss, R. H. A comprehensive urinary metabolomic approach
for identifying kidney cancer. Anal. Biochem. 363, 185–195 (2007).

2.

Lindon, J. C., Holmes, E. & Nicholson, J. K. Metabonomics in pharmaceutical R&D. FEBS J.
274, 1140–51 (2007).

3.

Joyce, A. R. & Palsson, B. Ø. The model organism as a system: Integrating ‘omics’ data sets. Nat.
Rev. Mol. Cell Biol. 7, 198–210 (2006).

4.

Ivanisevic, J. et al. Toward ’Omic scale metabolite profiling: A dual separation-mass spectrometry
approach for coverage of lipid and central carbon metabolism. Anal. Chem. 85, 6876–6884 (2013).

5.

Marshall, D. D. & Powers, R. Beyond the paradigm: Combining mass spectrometry and nuclear
magnetic resonance for metabolomics. Prog. Nucl. Magn. Reson. Spectrosc. 100, 1–16 (2017).

6.

Deng, L. et al. Combining NMR and LC/MS using backward variable elimination: Metabolomics
analysis of colorectal cancer, polyps, and healthy controls. Anal. Chem. 88, 7975–7983 (2016).

7.

Hao, J., Astle, W., De iorio, M. & Ebbels, T. M. D. Batman-an R package for the automated

11
quantification of metabolites from nuclear magnetic resonance spectra using a bayesian model.
Bioinformatics 28, 2088–2090 (2012).
8.

Ravanbakhsh, S. et al. Accurate, fully-automated NMR spectral profiling for metabolomics. PLoS
One 10, 1–15 (2015).

9.

Bingol, K., Bruschweiler-Li, L., Li, D. W. & Bruüschweiler, R. Customized metabolomics
database for the analysis of NMR 1H-1H TOCSY and 13C-1H HSQC-TOCSY spectra of complex
mixtures. Anal. Chem. 86, 5494–5501 (2014).

12

Chapter 2: Chemometrics and Machine Learning in Metabolomics
2.1 Introduction

Metabolomics is a rapidly growing field of study that endeavors to measure the complete set of
metabolites (generally considered to be the intermediates and products of cellular metabolism less than 1
kDa in size) within a biological sample (that is, the metabolome) in order to achieve a global view of the
state of the system1. Typically, metabolomics is focused only on characterizing the water-soluble
metabolites, whereas lipidomics is a specialized discipline that investigates only lipids 2. Water-soluble
metabolites are part of a mobile, open biological system and as a result can readily interact and
communicate with the environment, including the microbiome3. This is also true for some lipids but to a
much lesser extent. Consequently, metabolomics has become an essential resource for systems biology
because of its unique perspective relative to genomics and proteomics. Numerous studies have measured
the relative upregulation or downregulation of genes or proteins to infer changes in biological function.
However, it has been shown that even for common metabolic processes, such as glycolysis, a change in
the cellular concentration of an enzyme does not necessarily lead to a proportional change in metabolic
flux4. Thus, whereas genomics and proteomics identify what might happen, metabolomics identifies what
is actually happening in the system. This realization demands a different perspective and requires the
measurement of transcriptional, proteomic, and metabolomic data in order to obtain a complete picture of
the system’s response to environmental or genetic stress. As another illustration, a “silent mutation” does
not produce an observable change in phenotype despite an alteration in a gene or protein product.
Therefore, metabolomics profiling can be used to decode the function of silent mutations, such as the
Pfk26 and Pfk27 genes in Saccharomyces cerevisiae that both encode the glycolytic/gluconeogenesis
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regulator phosphofructokinase 25 . Via co-response and cluster analysis, these genes were observed to
exhibit similar metabolite profiles which differed from other genes impacting energy metabolism. For
these reasons, methods to directly measure metabolite concentrations within cells, tissues, organs, or other
biological samples are crucial for fully understanding a system when traditional omics studies (for
example, genomics, proteomics, and transcriptomics) are deemed insufficient. To date, nuclear magnetic
resonance (NMR)6and mass spectrometry (MS)7 have been the primary analytical techniques used to
characterize a metabolome. NMR and MS are typically combined with univariate and multivariate
statistical methods to identify major metabolite changes and to identify potential biomarkers 8 .
Nevertheless, despite the tremendous growth in the field, critical protocols and techniques are still under
development. Herein, we present recent advances in methodologies and statistical analysis that are
enhancing and improving the performance of metabolomics while extending the applications in which
metabolomics can play a significant role.
2.2 Essential Components of a Successful Metabolomics Investigation
Conceptually, an untargeted metabolomics study is quite simple. Biological samples are obtained
from two or more experimental groups to be compared (healthy versus diseased, wild-type versus gene
knockout, and so on) and the metabolites are extracted. These metabolic extracts then are measured by
using numerous instrumental techniques, of which NMR and liquid chromatography (LC)-MS are the
most common. The resulting spectra then are subjected to statistical analysis techniques such as principal
component analysis (PCA) and orthogonal projection onto latent structures (OPLS) to determine the most
significant spectral features that define each group9-10. Finally, these spectral features then can be assigned
to distinct metabolites and metabolic pathways by using spectral libraries of known metabolites 11-12. In
this manner, untargeted metabolomics is discovery-based since it reveals previously unknown information
about how a system responds to environmental or genetic stress. Conversely, targeted metabolomics
focuses on analyzing a specific set of metabolites on the basis of some prior knowledge about the system.
As a result, targeted metabolomics studies tend to be more sensitive and quantitative and have a higher
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reproducibility and a lower false-positive rate relative to untargeted metabolomics. Protocols for
obtaining and extracting the metabolome have been well developed and exhaustively reviewed for a wide
range of biological samples, including cell cultures, urine, blood/serum, and both animal- and plantderived tissues13-16. Although these protocols are readily available, the variable stability of metabolites
means that even minor changes in procedure can have a major impact on the observed metabolome. The
fast turnover rate of enzymes and the variable temperature and chemical stability of metabolites require
that metabolomics samples be collected quickly and handled uniformly and that all enzymatic activity be
rapidly quenched in order to minimize biologically irrelevant deviations between samples that may result
from the processing protocol13, 17,. Thus, the optimization of the sample preparation protocol is essential
to a successful metabolomics study. Conversely, the most likely source of bias is improper handling of
the metabolomics samples. An important consideration is that the complete metabolome cannot be
captured in a single extraction protocol. This is in stark contrast to modern genomics, which can reliably
cover the entire genome of an organism. A metabolomics extraction protocol will usually focus on only a
subset of metabolites (for example, water-soluble metabolites or lipids). Furthermore, an extraction
protocol may focus on either a highly reproducible and quantitative extraction of a restricted set of
metabolites (that is, targeted metabolomics) or the global collection of all possible metabolites (that is,
untargeted metabolomics) with a possible reduction in precision. In general, 200 to 500 metabolites may
be observed by targeted metabolomics, whereas upwards of 1,500 metabolites have been detected in
untargeted metabolomics studies18. Following extraction and subsequent data collection, the final and
perhaps most crucial step is metabolite assignment, which typically is accomplished by a comparison with
spectral libraries of known metabolites. This is not a trivial task since the number of possible metabolites
can be prohibitively large, and a large segment of the metabolome is either unknown or lacking a
reference spectrum. For example, the human metabolome is estimated to contain around 150,000
metabolites18, but the Human Metabolome Database12 contains only around 74,000 metabolites (as of 1
June 2017). Thus, there are still many unknown metabolites and a true estimate of the size of the human
metabolome is challenging19. Another complicating factor is that different organisms may have
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completely unique metabolomes. For instance, plants have over 45,000 known secondary metabolites 20.
Finally, there may be ambiguities in making a metabolite assignment because of chemical shift overlap or
identical masses (for example, isomers). As a result, the assignment of metabolites to spectral features
may be as low as 4 to 5%21.
2.3 A Tale of Two Methods: Mass Spectrometry or Nuclear Magnetic Resonance?
Perhaps the most important choice that can be made in a metabolomics study is which
instrumental platform is used. Although a wide range of instruments have been used for metabolomics,
including capillary electrophoresis, infrared spectroscopy, and Raman spectroscopy, only NMR and MS
are routinely used for metabolomics. NMR and MS are often applied in metabolomics investigations
because of their inherent complementarity, which results from their distinct advantages and
disadvantages22. NMR is highly reproducible and quantitative, has simple sample preparation protocols,
and is able to measure analytes over a wide range of solvent conditions 23. Despite these advantages, the
main limitation of NMR is its low sensitivity, which restricts its application to measuring the most
abundant metabolites in the sample (micromolar to millimolar range). This has been noted as a significant
hurdle that has slowed the widespread adoption of NMR by the metabolomics community6, 22-23.
Conversely, the high sensitivity and low detection limits of MS enable the detection of subtle metabolic
changes that are invisible by NMR. With this increase in sensitivity, the detection of thousands of peaks is
relatively common24, but untargeted MS metabolomics studies often are not quantitative in nature. Since
MS detectors rely on ionization processes, MS is restricted to detecting metabolites that readily ionize.
Correspondingly, a significant reduction in observable metabolites may occur depending on the specifics
of the sample being considered25. For a detailed overview of the utility of various MS detectors to
metabolomics, see the review article by Dunn et al. 26
MS also suffers from reproducibility problems since contaminants within the sample can change
the ionization efficiency of metabolites2 . Specifically, quantitation is challenging in untargeted MS since
peak intensity is dependent on ionization efficiency, which varies between metabolites and also is
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strongly dependent on experimental conditions that may result in varying ion suppression 27. One issue of
particular relevance to MS is the relatively narrow nominal mass and mass defect distribution of the
metabolome which results in significant peak overlap28. This can be resolved by coupling MS to a
chromatographic method, most commonly LC or gas chromatography (GC), to resolve overlapping peaks
and to aid in the metabolite identification based on retention time and the properties of the stationary
phase. GC was the first separation technique applied to the analysis of metabolic mixtures; for example,
GC-MS was used to identify biomarkers for diagnosing phenylketonuria in 1970 29. GC-MS is particularly
beneficial for the analysis of volatile metabolite mixtures since minimal sample preparation is required; in
some cases, samples can be directly analyzed. Furthermore, a number of applications of GC-MS uniquely
involve detecting volatile metabolites; two examples are the measurement of exhaled breath condensates
for diagnosing lung cancer30 and the monitoring of volatile paper degradation products from historic
books31. An obvious disadvantage of GC-MS is its reliance on analyte volatility, where metabolites of low
volatility or low temperature stability may be modified or destroyed17. Limited metabolite volatility can
be overcome through the use of derivatization schemes, but derivatization is time-consuming. More
importantly, differences in the efficiency of the derivatization32 and differences in the stability of the
derivatized metabolites17may dramatically perturb the apparent concentrations of the metabolites, possibly
leading to an erroneous biological conclusion. LC was not widely used for metabolomics until the 1980s 26
and this was due to technical limitations with interfacing LC and mass spectrometers. A main advantage
of LC over GC is that most metabolites can be detected intact and without modification from a
deravitizing agent. Additionally, LC provides an accurate analysis of thermally unstable or reactive
metabolites since the separation typically occurs at room temperature. However, the introduction of a
liquid phase does introduce a higher variability in retention times 33, an increase in ion suppression due to
matrix effects34, and a lower resolution relative to GC. NMR and MS tend to observe a distinct set of
metabolites from the same metabolomics sample. Consequently, there is a growing trend in metabolomics
to perform tandem studies in which the same sample is analyzed by both NMR and MS 35-38. In this
manner, the coverage of the metabolome is significantly increased by taking advantage of the strengths of
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both methods. NMR identifies trends in metabolic alteration along core metabolic pathways and provides
a context for the interpretation of the low-abundance metabolites identified by MS. Of course, the
combined use of NMR and MS leads to a proportional increase in data set size with the added complexity
of the simultaneous processing, analysis, and interpretation of two dissimilar data types.
2.4 Practical Concerns in Data Processing and Interpretation
Metabolomics experiments generate large data sets that require specialized tools for analysis.
Numerous software packages for data pre-processing and statistical analysis are available and have been
reviewed elsewhere39-40. Unfortunately, no single software exists that can simultaneously perform all of
the critical steps needed for an analysis of a combined NMR and MS data set. Although the statistical
techniques applied to NMR and MS data sets are largely the same, each technique requires a unique set of
pre-processing tools and algorithms prior to modelling. For example, an NMR spectrum has to be
Fourier-transformed and phased, whereas centroiding and de-isotoping are required in MS. Owing largely
to these data type–specific processing requirements, newly developed software is almost exclusively
restricted to one method or the other. Conversely, there has been minimal effort in developing tools
capable of working with both NMR and MS data sets39. There are two general approaches to integrating
NMR and MS data sets into a single coherent study. The first involves samples simply being
independently analyzed by each method. The separate data sets then are compared in order to identify
consistencies in the metabolic alterations observed by each technique. The main advantage of the
approach is simplicity since it does not require any significant protocol changes. Also, the confidence of a
metabolite assignment may be significantly increased if it is identified by both methods. Furthermore, a
measure of internal consistency may be achieved if metabolite concentrations can be estimated by both
methods. However, significant information can be lost during this process since, for example, ambiguity
in peak assignments sometimes can be resolved by information from the other method. There is also a
lack of statistical correlation since the data sets are independently analyzed. Although the manual curation
of independent data sets is the dominant method currently used by metabolomics investigators, it also
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suffers from reproducibility problems due to potential biases in data interpretation (for example,
metabolite assignment methods) among other issues. The second approach to combining NMR and MS
data sets is to simultaneously integrate each data set into a single statistical model using a multiblock
analysis. Multiblock analysis encompasses a variety of methods that combine multiple data sets prior to
conventional multivariate analysis. In addition to combining multiple instrumental data sources42,
multiblock analysis has been successfully employed to combine data sets from different omics
disciplines41. Multiblock methods are preferable to independent analysis since the relative contributions of
each data set still can be quantified, but importantly the larger combined data set is likely to result in
models with greater predictive ability and resolving power than either method alone 42. However, the
software tools to perform multiblock analyses are crude and often rely on custom sets of pre-processing
routines using multiple software packages. The lack of integrated analysis tools and software is a major
roadblock in metabolomics, especially in light of the growing interest in combining NMR and MS data
sets.
2.5 Recent Advances in Metabolomics
2.5.1 Dynamic Nuclear Polarization
NMR metabolomics investigations, especially those concerned with achieving a high confidence
in metabolite identification, require two-dimensional NMR methods to resolve the overlap present in onedimensional spectra. In general, this requires isotopic labelling with NMR-active nuclei like 13C and 15N
because of their low natural abundance. In the last few years, dynamic nuclear polarization (DNP) has
evolved from a structural biology tool in the area of solid-state NMR to have potential applications in
solution-state metabolomics43. In DNP, a solid, frozen metabolomics sample at about 1.5 K is polarized in
the presence of microwave-irradiated free-radicals, which induces a temporary hyperpolarization in
spinactive nuclei through a transfer of polarization from electrons to nuclei. The sample then needs to be
rapidly melted and transferred to an NMR spectrometer to take advantage of the greatly enhanced
sensitivity (>10,000-fold)44. The dramatic increase in sensitivity avoids the need for isotopic labelling,
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especially for in vivo samples, and may permit the detection of low-abundance metabolites. Nevertheless,
DNP experiments are limited by T1 relaxation rates, resulting in a short measurement window of the
dynamically polarized samples. DNP also requires substantial hardware modifications and accessories
(for example, microwave generator) to rapidly thaw and shuttle samples back and forth from the NMR
spectrometer. DNP has also been applied to 13C-labeled metabolites that then are used as a tracer
compound for in vivo imaging45. This requires close proximity of the polarizer and magnetic resonance
imaging spectrometer to allow for rapid transfer, dissolution, and injection of the 13C-labeled metabolite
given the relatively short T1 of 30 to 40 seconds for a 13C-labeled carboxyl group. Despite these
technical obstacles, DNP has been successfully used to monitor a single metabolite (for example,
pyruvate) in living tissue (for example, heart) by magnetic resonance imaging46. Besides the short
measurement time, another challenge with the application of DNP to in vivo imaging is the limited
number of 13C-labeled metabolites that can be polarized and tolerated at the concentrations needed for
imaging (25 to 80 mM) and that are also a useful biological probe. In addition to pyruvate, bicarbonate,
fumarate, urea, glutamine, and dehydroascorbate have been used for in vivo imaging45. Despite
fundamental issues of reproducibility and limitations in sample preparation, DNP protocols and
technology are rapidly advancing and one day could become a routine tool for metabolomics 47.
2.5.2 Disease Profiling and Personalized Medicine
Metabolomics can be used to profile an individual’s responses to a drug treatment or other
medical therapy by monitoring metabolite changes in readily obtainable biofluids (for example, blood and
urine). A unique advantage of metabolites as biomarkers is the likely occurrence of observing a set of
multiple metabolites with distinctly different concentration changes that are correlated with a disease state
or treatment response. Correspondingly, multiple metabolites, instead of a single biomarker, are expected
to yield a higher sensitivity and selectivity. For example, plasma baseline levels of xanthine, 2hydroxyvaleric acid, succinic acid, stearic acid, and fructose prior to simvastatin treatment were observed
to reliably predict a good or poor response in reducing low-density lipoprotein cholesterol 48. The OPLS
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model yielded a 70% sensitivity and 79% specificity with a corresponding area under the receiver
operating characteristic curve of 0.84. Thus, metabolomics can be used to predict whether a patient will
respond to a drug in addition to being used as a semi-quantitative prognosis of disease progression. For
example, in a recent study of patients with tuberculosis (TB), urine samples that were collected over the
course of a 6-month period became more similar to those of a non-TB control group during the course of
first-line anti-TB therapy (for example, isoniazid, ethambutol, or pyrazinamide). Metabolomics has also
been successfully employed to identify serum metabolic alterations associated with psoriasis 49.
Importantly, the metabolomics results were consistent with trends previously observed in genomics and
proteomics studies. The metabolome changes were observed to reverse following successful
corticosteroid treatment50. Interestingly, the authors identified an increased demand for glutamine, which
had not been previously reported in psoriasis.50-51
Glutamine demand is directly associated with diseases characterized by increased cellular
proliferation, such as in cancers. A significant alteration in β-isosterol, which is a commonly employed
herbal remedy, was also observed. Thus, metabolomics may also be used to identify a patient’s use of
alternative treatments outside of his or her physician’s knowledge or recommendation. In this manner,
metabolomics may assist in determining whether co-administration of a complementary treatment was
beneficial or detrimental to a patient’s therapeutic outcome.
2.6 New Trends in Data Analysis
Much of the data analysis approach in metabolomics has been largely borrowed from the field of
chemometrics, which pioneered the application of PCA and PLS to chemical systems 52. Although these
are powerful statistical tools, the current trend in metabolomics data analysis is evaluating the efficacy of
new algorithms and statistical methods to improve group separation and metabolite identification. PCA,
PLS, and OPLS are all commonly employed by metabolomics investigators, but newer approaches,
including support vector machine (SVM53), random forest (RF)54, and self-organizing map (SOM)55
algorithms, have all been recently applied to metabolomics data sets.
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Despite having been formalized since 199256, SVM has been used extensively only in the analysis
of gene microarray data, particularly due to its performance on data sets characterized by a large number
of variables and few samples57[mukerjee]. SVM is also able to identify nonlinear relationships that violate
the linearity assumptions of PCA and OPLS, making it easily generalizable. SVM has been recently
applied in biomarker discovery for ovarian cancer, and a model using serum-derived LC-MS spectra was
able to predict disease onset with higher accuracy than the currently accepted method of CA-125 serum
monitoring58. A major caveat of SVM is its restriction to binary classification problems: it is able to
discriminate between only two experimental groups. Simply, spectra belonging to two experimental
groups are represented as points in n-dimensional space, where n corresponds to the number of observed
metabolites. A hyperplane then is calculated that best separates the points from the two groups. The
coefficients of the calculated hyperplane are used to determine which metabolites are most important for
discriminating between the two groups. Although methods have been proposed to extend SVM to multiclass problems, they are often done by breaking down the data set into an ensemble of binary groups that
oversimplifies the problem and leads to uninformative models59.
The RF algorithm is a decision tree–based method that uses random subsets of the data to
construct multiple models, which then are combined to create an average model in a process known as
bootstrap aggregation. In the decision tree method, samples are mapped to a target value (that is, which
experimental class the sample belongs to) using a set of variable-based decision rules that separate the
samples into groups corresponding to the target value. These newly formed groups can be further
subdivided according to new variables, and each “branch” of separation is repeated until the samples can
be fully differentiated. The major advantage of the decision tree is its imperviousness to scaling and
variable normalization, an extremely common problem in metabolomics data 60. The disadvantages
include an extreme propensity for overfitting and having extremely poor generalizability that severely
limits its utility. RF addresses this limitation by creating an ensemble of partial decision trees that, when
combined into an overall model, reduces variance and overfitting61. In particular, the RF algorithm, being
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relatively unaffected by scaling and normalization and easily handling both large data sets and missing
values, is highly adaptable to the realities of real-world data sets. A major disadvantage of RF is that the
method requires extensive “tuning” of default parameters by the investigator in order to obtain the best
model. Also, the resulting decision tree can be hard to visualize for large data sets62. RFs have shown
clinical value: they have been used to determine a set of serum protein and metabolic biomarkers in
prostate cancer with higher predictive accuracy than the current prostate-specific antigen biomarker 63-64.
See Gromski et al. (2015) for an excellent review of the SVM and RF algorithms that also includes
comparisons with other mainstream techniques62. SOM is an approach similar to PCA that reduces multidimensional problems to a more easily interpretable low-dimensional grid to visualize natural clustering
trends and groupings within a data set. SOM can be applied to the same tasks as PCA but without the
biases toward high-variance metabolites. SOMs, like SVM, have the ability to detect non-linear
relationships between detected metabolites68. SOMs have been successfully applied to develop
biomarkers for early-stage renal cell carcinoma as well as to predict patient response to surgical
intervention with a predictive accuracy of 94.74%65. In comparison with the other statistical methods,
SOM has been severely limited in metabolomics because of a computationally intensive algorithm and the
lack of a pre-packaged software, which has significantly diminished its accessibility to the wider research
community66. Nevertheless, the usage of SOMs in metabolomics is steadily rising, and comparative
analyses are beginning to demonstrate that SOMs are an acceptable alternative to more traditional
clustering algorithms67.
In addition to statistical methods applied directly to spectral profiles, identified metabolites can be
used with pathway analysis68 to understand metabolite interactions with known pathways or to discover
mechanisms of action in pharmaceutical natural product research73. Metabolomics data sets can generate
an overwhelming and seemingly disjointed list of metabolites, which pathway analysis aims to place into
a broader biological context by assigning metabolites to relevant metabolic pathways. This is done
through a number of software tools that integrate putatively identified metabolites with pathway
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information from various databases. For example, MetaboAnalyst 3.0 is a suite of metabolomics tools
(http://www.metaboanalyst.ca), which includes modules for metabolite enrichment analysis (MSEA),
metabolite pathway analysis (MetPA), and an integrated pathway analysis. The user input is typically a
list of metabolites (with or without concentrations) or genes or both. MSEA provides a ranked list of
potentially key metabolic pathways based on the observed number of metabolites associated with that
pathway (that is, metabolite set enrichment)69. MetPA combines MSEA with a pathway topology analysis
to provide an overall pathway analysis to identify the metabolic pathways primarily impacted in the
study68. The integrated pathway analysis combines both metabolomics and genomics data with
enrichment analysis and topology analysis to again identify the pathways (in rank order) that were
primarily impacted in the study70. MetaboSignal (https://bioconductor.org/) is an alternative approach to
pathway analysis which employs directed graphs with network topology approaches to compute centrality
measures to correlate genemetabolite relationships through shortest-path distances71. Thus, unlike the
MetaboAnalyst 3.0 tools, the output of MetaboSignal is a network map of gene-metabolite connectivities.
Cytoscape (http://www.cytoscape.org/) is a generalized network interaction and visualization tool that
works with a variety of data sets, including metabolomics data. Cytoscape combined with MetScape 3
(http://metscape.ncibi.org/)72 can generate network maps similar to those of MetaboSignal from
metabolomics or genomics data or both78. MetScape uses known pathways from Kyoto Encyclopedia of
Genes and Genomes (KEGG)73 and Edinburgh Human Metabolic Network (EHMN) 74 databases and gene
set enrichment analysis to generate these networks in order to visualize the impacted metabolic pathways.
In essence, there is some significant overlap in the capabilities of MetaboAnalyst 3.0, MetaboSignal, and
Cytoscape/MetScape 3. Importantly, pathway analysis provides an interaction network that may identify
centralized hubs where metabolic pathways coincide or where bottlenecks may occur. The limited
connectivity or altered flow through specific metabolic nodes (that is, change in metabolic flux) may
identify functionally essential biological processes75. These essential pathways then can be selectively
targeted. By genetically or chemically restricting a potentially essential metabolic pathway, it is possible
to ascertain the relevance of the pathway to a systems response to an environmental stress (that is, drug
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resistance) and potentially reverse or negate the response76. Pathway analysis also allows for the
integration of multi-modal omics data, such as combining gene-expression and metabolomics data to
uncover gene and protein functions. For example, metabolite profiles were integrated with genome-wide
screening of single-nucleotide polymorphisms (SNPs) to identify the molecular mechanism of the NAT8
and PYROXD2 genes. Briefly, SNPs were ranked according to the strength of an association with
observed metabolites. The regions where these SNPs occur on the chromosomes then were screened to
determine at what position in the genome the gene/protein product responsible for the mediation is stored.
With this approach, it was suggested that the NAT8 and PYROXD2 genes were responsible for mediation
of serum diethylamine levels77, a novel insight for these previously under-annotated genes.
As another illustration, transcriptomic and metabolomic data from Arabidopsis thaliana were
integrated to characterize the biological response resulting from the over-expression of PAP1, a gene
known to cause profound accumulation of anthocyanins and to encode a MYB transcription factor
regulating flavonoid biosynthesis. The authors were able to correlate the biosynthesis of cyanidin and
quercetin derivatives with a specific set of upregulated genes that enabled them to identify the function of
two uncharacterized proteins: a flavonoid 3-O-glucosyltransferase and anthocyanin 5-Oglucosyltransferase78. Numerous tools are now available for pathway analysis of metabolomics data 73, 7980

, which will significantly improve data interpretation and simplify our understanding of biological

relevance. Thus, pathway analysis is becoming a routine component of a detailed metabolomics analysis.
2.7 Concluding Thoughts: What does the future hold?
The recent advancements in metabolomics outlined herein have been shown to enhance its utility in
systems biology research and to have a beneficial impact on medical research and personalized medicine.
The measurement of metabolomics profiles has been shown to be useful for monitoring treatment
efficacies from both pharmaceutical and surgical interventions. As our understanding of the relationship
between disease state and the chemical profile of biofluids grows, metabolomics is expected to become a
routine approach for monitoring disease development and progression, as a tool for disease diagnosis, and
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for understanding the underlying molecular mechanisms of drug resistance. Metabolite profiles could be
obtained at regular intervals and screened for changes over a patient’s lifetime as a diagnostic tool and a
means to monitor a patient’s overall health status. Some of this work has already begun; an ongoing
Alphabet (parent company of Google) “moon-shot project” is a baseline study attempting to determine the
inherent level of variability in human medical data that is not associated with a disease. Though still in its
infancy, a similar approach using metabolomic profiles may be used to determine the inherent variability
in biofluid profiles for healthy individuals. In this manner, metabolic profiles associated with disease
onset and progression can be easily distinguished from the known variance in healthy individuals Some of
the biggest challenges remaining in the field of metabolomics involve fundamental limits in experimental
methodology. Metabolomics requires relatively high-cost instrumentation and complex data analysis and
still suffers from issues of sample-to-sample variability. Although great strides in each of these areas have
been made, there is still more work to be done before metabolomics can become a key and routine part of
a clinical practice. Nevertheless, metabolomics continues to make important contributions to both medical
research and general systems biology studies. In fact, the ability to directly measure metabolite
concentration changes by using a targeted NMR or MS approach would greatly benefit investigations into
a range of research areas that often are overlooked by other methods. In this manner, a metabolomics
assay that targets a select and specific set of metabolites can be used to develop a highly reproducible and
quantifiable assay that can be translated into a validated clinical assay.
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Chapter 3: The role of Normalization in Metabolomics
3.1 Introduction
High-throughput facilities continue to improve the acquisition and throughput of OMICS experiments
(e.g., genomics, transcriptomics, proteomics, and metabolomics), which has resulted in the rapid
accumulation of large amounts of data. These massive datasets have enabled the detection and
quantification of thousands of genes, proteins, and metabolites across various biological samples.
Accordingly, OMICs data has significantly contributed to a variety of fields including drug discovery 1,
personalized medicine2, nutrition3 and environmental studies4. Perturbations or variance are inherent to all
experimental datasets and come from a variety of sources such as biological variability, instrument
instability, and inconsistency in sample handling and preparation. For example, the number of cells
harvested, the mass of tissue collected, or the amount of urine produced may vary significantly across all
of the biological replicates. These unavoidable variations may mask the real biological signals present in
the samples, which, in turn, complicates the reliability and accuracies of all downstream quantitative
analyses5. Accordingly, the preprocessing of OMICs data is a critical step and involves minimizing
undesirable noise to make all subsequent analyses more robust, accurate, and precise 6. One crucial
preprocessing step is the normalization of data, which has been shown to effectively reduce systematic
noise in OMICs datasets7. Normalization of OMICS datasets can be accomplished using a variety of
methods8,9. But, the proper choice depends on data characteristics and the sources of variation that needs
correcting. How well a specific normalization technique performs in reducing these extraneous biases is
still an open question. Accordingly, identifying an optimal normalization technique is still a common
issue encountered throughout the OMICs fields. For example, in genomics, differences in sequencing
length (library size), gene length, or guanine–cytosine content may lead to data variance and a false
interpretation of gene expression variability10Thus, an appropriate normalization method needs to
eliminate these sources of variance to ensure an accurate measure of gene expression levels. To address
this issue, Choe et al. examined four popular normalization methods routinely used in genomics that
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included: constant sum, rank-invariant, LOcally Estimated Scatterplot Smoothing (LOESS), and
quantile11.The normalization algorithms were compared using RNA-microarray data. The LOESS
normalization algorithm assumes a non-linear relationship and uses a local regression approach to adjust
signal intensity and noise. Incorporating LOESS normalization into the analysis of the RNA-microarray
data yielded superior results relative to the other normalization techniques. LOESS improved the
detection of true differentially expressed genes as evident by the largest area under the receiver operating
characteristic (ROC) curve. Similarly, Callister et al. evaluated four normalization techniques routinely
used in proteomics12. Central tendency, linear regression, locally weighted regression, and quantile
normalization algorithms were compared using three sets of samples representing different levels of data
complexity. The linear regression normalization algorithm was identified as the top performer since it
exhibited the largest reduction in extraneous variability while also maintaining the highest reproducibility
as measured by both pooled estimate of variance and a median coefficient of variance. Metabolomics
characterizes both the identity and the quantity of metabolites present in a biological sample 5. Since
metabolites are a direct product of cellular processes, the metabolome is able to accurately capture the
current state of the system. Thus, even subtle changes in metabolite concentrations may provide important
insights into disease progression13, drug resistance14, or a response to numerous stress factors (e.g.,
environmental toxins, nutrient limitation, genetic mutation, etc.)15–17. Unfortunately, like genomics and
proteomics, these metabolite differences are easily obscured by the natural variance that occurs between
biological replicates or by inconsistencies in sample sizes. Furthermore, since nuclear magnetic resonance
(NMR) spectroscopy5 is routinely used to monitor the metabolome, instrument instability and
experimental factors such as changes in pH, temperature, ionic strength or even sample composition may
lead to unintended signal variance6. Such non-biologically induced perturbations are likely to mask the
true biological signals in the data and complicate the data analysis process. Again, normalization is a
necessary requirement to minimize these undesirable variations and to increase the accuracy and
reliability of all subsequent data analyses. A variety of procedures are currently available to normalize
NMR metabolomics data8,16. Since each algorithm addresses systematic variations in a different manner,
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the correct choice of a normalization scheme can be challenging. For example, some normalization
algorithms aim to remove unwanted noise by minimizing inter-sample variation such as probabilistic
quotient6 and cubic splines methods18, while others such as unit variance or Pareto (often referred to as
scaling), aim to adjust the variance of spectral features so that all peaks are equally weighted when used
to construct multivariate models such as principal components analysis (PCA). Since these algorithms
were developed with different underlying assumptions, each method confers a unique set of advantages
and disadvantages. For example, Craig et al. , demonstrated that while constant sum normalization
adequately preserves signal quality, it can change the underlying correlations between peaks and generate
artifacts19. Thus, constant sum may confound interpretations when used incorrectly. A comparative
analysis of normalization schemes by Kohl et al. determined that quantile normalization significantly
outperforms other approaches in both minimizing inter-sample standard deviation and accurately
preserving fold change information5. However, it was also noted that the performance of quantile
normalization was only truly realized for large datasets (n≥50) and offers no significant performance
benefits on more modestly sized datasets. The diversity of normalization algorithms and the lack of a
clear consensus has provided the motivation to conduct a thorough and quantitative evaluation of
normalizing methods currently available to the metabolomics community through our MVAPACK
software package20. MVAPACK is open source software (http:// bionmr.unl.edu/mvapack.php) that
includes a complete set of functions for data loading, preprocessing, modeling, and validation of NMR
metabolomics datasets. MVAPACK also includes the following normalization methods: probabilistic
quotient (PQ)6 , histogram matching (HM)21, standard normal variate (SNV)22, multiplicative scatter
correction (MSC)23, quantile (Q)5, natural cubic splines (CSpline)18, smoothing splines (SSpline)24,
constant sum (CS) and region of interest (ROI)6. Our phase-scatter correction (PSC) algorithm is also
available in MVAPACK, but was not included in this comparison since PSC was previously discussed in
detail 25. The normalization methods were compared using simulated and experimental NMR datasets
with various levels of added noise and dilution factors26. Their performances were evaluated based on an
ability to recover the intensities of the true spectral peaks and the reproducibility of true classifying
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features from orthogonal projections to latent structures—discriminant analysis (OPLS-DA) model 27. In
this manner, the normalization methods were evaluated based upon expected outcomes for routine
metabolomics study: (i) the ability to eliminate irrelevant signal variance due to dilution factors and noise;
and (ii) the ability to produce a predictive model that correctly identifies the real group-dependent
variants. Our analysis indicates that of the normalization algorithms evaluated, PQ and CS performed the
best in the analysis of noisy one-dimensional (1D) NMR metabolomics datasets.
3.2 Methodology
The performance of each normalization method was assessed using two distinct datasets: (i)
simulated spectral data and (ii) a previously described experimental data set of 1D 1 H NMR spectra of
various coffee samples26.All of the analyses were conducted using our MVAPACK 20 software package.
All of the figures were generated using the R software package28.
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Figure 1. The simulated reference spectrum used for (A) group 1 and (B) for group 2. The two spectra
contain the same number of peaks at the same chemical shifts. The only difference between the spectra is
the relative peak intensities.
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3.3 Simulation of a 1D 1H NMR Metabolomics Dataset
The simulated dataset consisted of 50 spectra in which each spectrum contained 901 spectral features. The
set of spectra were divided into two separate groups. Each group consisted of 25 spectra that were
randomly generated from a reference spectrum. The reference spectrum for each group was independently
simulated from the Cauchy distribution29, but with different parameters. Each reference spectrum contains
four peaks located at chemical shifts of 3, 3.2, 3.5, and 8 ppm, respectively. The peak intensities differ
between the four peaks and between the two reference spectra as illustrated in Fig. 1. The 25 spectra per
group were generated from the reference spectrum by the addition of a minimal amount of Gaussian noise
(Mean = 0, SD = 0.001). These two sets of 25 spectra, which correspond to group 1 and group 2, were
combined to define the simulated reference dataset X0 (N=50, K=901). The simulated reference dataset
X0 was then used to generate eight noise-added simulated sets (Xi ) (Fig. S1) with i = 1, 2, …, 8 (Table 1)
according to Eq. (1):
𝑿𝒊 = 𝑭𝒊 ∗ (𝑿 + 𝑬𝒊 )

(1)

where Fi is a 50×1 vector of dilution factors generated from a uniform distribution for the ith set, Ei is a
matrix of independent Gaussian noise distributed with mean 0 and standard deviation 𝜎 i for the ith set,
and * presents element-wise multiplication. The value of 𝜎 i ranged from 0.1 to 5 which produced a
systematic increase in noise for the dataset. The CS, PQ, HM, SNV, MSC, ROI, Q, CSpline, and SSpline
normalization methods were then separately applied to each noise-added set (Xi ) to obtain normalized set
(X̃ i ). An OPLS-DA model was then generated from each normalized set (X̃ i ). Two-component OPLSDA models were calculated to obtain the first component loadings to compare the performance of the
normalization approaches.
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Table 1: Parameters used to generate the noise-added simulated spectra
Set

Dilution Factors (F)a

S1

~ 𝑈𝑛𝑖𝑓(0.9, 1.1)

0.1

5%

S2

~ 𝑈𝑛𝑖𝑓(0.9, 1.1)

0.2

10%

S3

~ 𝑈𝑛𝑖𝑓(0.8, 1.2)

0.4

20%

S4

~ 𝑈𝑛𝑖𝑓(0.5, 1.5)

1

50%

S5

~ 𝑈𝑛𝑖𝑓(0.3, 1.7)

1.4

70%

S6

~ 𝑈𝑛𝑖𝑓(0.1,1.9)

1.8

90%

S7

~ 𝑈𝑛𝑖𝑓(0.01, 2.5)

2.5

100%

S8

~ 𝑈𝑛𝑖𝑓(0.001, 5)

4

200%

a

Standard Deviation (𝜎)b

Percent Added Noise

A dilution factor was randomly selected from the indicated range of values.

b

The value of standard deviation used to generate a Gaussian distribution of noise.
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3.4 Experimental 1D 1H NMR Metabolomics Dataset
A data matrix of 32 1D 1 H NMR spectra from a publicly available coffees dataset was used to further
evaluate the normalization algorithms26.The coffees dataset contains two groups defined as light and
medium decaffeinated coffee consisting of 16 1D 1 H NMR spectra per group. Each spectrum contains
284 spectral features. We applied the same procedures as described above to generate the noise-added
experimental dataset. Specifically, the original coffees dataset of 32 1D 1 H NMR experimental spectra
was designated as the reference data set Y0 (N=32, K=284). The reference data set Y0 was then used to
generate seven simulated sets (Yi ) with i = 1, 2, …, 7 (Table 2) according to Eq. 2:
𝒀𝒊 = 𝑭𝒊 ∗ (𝒀 + 𝑬𝒊 )

(2)

where Fi is a 32×1 vector of dilution factors generated from a uniform distribution for the ith set, Ei
(N=32, K=284) is a matrix of independent Gaussian noise distributed with mean 0 and standard deviation
𝜎 i for the ith set, and * presents element-wise multiplication. The value of 𝜎 i ranged from 2.3 × 10−7 to
10−5 which produced a systematic increase in noise while also mimicking the relative variance in the
noise present in the coffees dataset.
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Table 2. Parameters used to generate the noise-added coffees dataset
Set

Dilution Factors (𝑭)a

Standard Deviation (𝜎)b

Percent Added Noise

C1

~ 𝑈𝑛𝑖𝑓(0.9, 1.1)

2.3 × 10

5%

C2

~ 𝑈𝑛𝑖𝑓(0.8, 1.2)

4.6 × 10

10%

C3

~ 𝑈𝑛𝑖𝑓(0.5, 1.5)

9.3 × 10

20%

C4

~ 𝑈𝑛𝑖𝑓(0.3, 1.7)

2.3 × 10

50%

C5

~ 𝑈𝑛𝑖𝑓(0.1, 1.9)

5 × 10

100%

C6

~ 𝑈𝑛𝑖𝑓(0.01,2.5)

8 × 10

170%

C7

~ 𝑈𝑛𝑖𝑓(0.001, 5)

10

200%

a

A dilution factor was randomly selected from the indicated range of values.

b

The value of standard deviation used to generate a Gaussian distribution of noise.
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3.5 Summaries of Employed Normalization Procedures
Constant sum: Each spectrum of the data matrix was divided by its own integral 6.
Probabilistic quotient The normalization factor was the most probable quotient between the signals of the
corresponding spectrum and the reference spectrum6. The reference spectrum was chosen as the median
spectrum of the spectral set. Each spectrum in the dataset was divided by this normalization factor to
obtain the normalized spectrum.
Histogram matching: Raw spectra were log transformed prior to normalization. Similar to PQ, the target
reference spectrum was the median spectrum of the dataset. Histograms for each sample spectrum and
target spectrum were obtained on prespecified intensity intervals. A dilution factor was then chosen to
minimize the differences between each sample spectrum histogram and the target histogram21.The new
normalized spectrum was generated by multiplying each original spectrum by the corresponding dilution
factor.
Standard normal variate: Each sample spectrum in the dataset was centered prior to normalization. The
standard deviation of each spectrum was calculated as a normalization factor 22. A new normalized dataset
was then obtained by dividing each original spectrum by its corresponding normalization factor.
Multiplicative scatter correction: The normalization factors were least squares estimates obtained by
regressing each sample spectrum onto the reference spectrum23.The reference spectrum was the mean
spectrum. The ordinary least squares of the regression parameters were used to correct the spectral
intensities.

Region of interest: Each sample spectrum of the dataset was normalized to a specified spectral region
where its integral was set to one. Each sample spectrum was then normalized relative to the most intense
peak in the spectrum.

45
Quantile: The goal of this quantile normalization method was to obtain an identical distribution of
intensities for all of the spectral features5.First, the mean spectrum was calculated for the data set. The
intensities of all features in each sample spectrum were then replaced by the mean intensities in
accordance with their quantile orders.
Natural cubic splines: The CSpline method normalized each sample spectrum to the target spectrum. The
target spectrum was calculated using the non-linear arithmetic mean of the data set. Depending on the
type of data, a geometric mean may also be used 5.A set of 100 quantiles was taken from both the sample
spectrum and the target spectrum. The quantiles were then fitted to a natural cubic spline to obtain
parameter estimates, which were used for interpolations. The process was repeated five times. For each
iteration, a small offset was added to the quantiles before refitting with a natural cubic spline to obtain
new interpolations. The set of interpolations were averaged to obtain the normalized spectrum.
Smoothing splines: SSpline is similar to CSpline, but the SSpline algorithm adds more quantiles toward
the tail end of the spectrum. The most intense spectral features are located in this region of the spectrum.
Moreover, the quantiles are fitted with a smoothing spline that includes a penalty parameter to avoid
overfitting. The predicted feature intensities were then used as the normalized intensities.

3.6 Evaluation criteria
Regardless of the type of approach used to address dataset bias or variance, an optimal
normalization procedure should reduce any unwanted noise while still preserving the true biological
signals. In other words, a necessary condition to retain the true signals is the ability to recover the original
peak intensities after removing noise. In this regards, it should be possible to evaluate the relative
performance of normalization methods based on how well the algorithms handle increasingly noisy
spectra. As the reference set is exposed to increasing amounts of noise, some (or all) of the normalization
algorithms would be expected to fail to recover the original peaks intensities. Thus, the peak recovery
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criteria served as a means to filter-out poorly performing normalization procedures prior to proceeding
with the second evaluation criteria. A multivariate statistical model, such as PCA or OPLS, is typically
employed to identify spectral features that separate the different groups in the dataset. These spectral
features are intrinsic to the dataset. Accordingly, any properly normalized dataset should reproduce these
true set of features. The first component loadings extracted from an OPLS-DA model contains the
weights of the spectral features that contribute the most to separating the groups. Simply, the first
component loadings identify the most-important group-dependent features. Thus, an OPLS-DA model
was generated to obtain the first component loadings associated with each normalization method. Only
the top performing normalization methods were used to generate an OPLS-DA model. The top
performing normalization methods were identified based on the peak recovery criteria. Pearson
correlation coefficients were calculated between the loadings of each normalized dataset and the true
loadings set. The Pearson correlation coefficients provide a means to measure the reproducibility of the
true classifying spectral features produced by each normalization algorithm.

3.6.1 Peak recovery
After sequentially normalizing each noisy data matrix using the nine normalization methods, the
intensity of each peak in each spectrum of the normalized set (X̃ i ) was compared T. Vu et al. 1 3 108
Page 6 of 10 to the true original spectrum (X0) to measure the recovery of peak intensities (rpi j i ). For
each spectrum from the normalized data matrix (X̃ i ), the recovery of the jth peak was calculated
according to this Eq. 3:

𝑟𝑝𝑖 = 1 −

(|

,

(3)

47
where I j i and I j 0 are the intensities of the jth peak from X̃ i and X0, respectively. In this manner, rpij i
will range from 0 to 1 regardless of the relative magnitudes of I j i and I j 0. This process was repeated for
every peak in each spectrum. The mean recovery and standard error were calculated and reported for each
normalized set.
3.6.2 Pearson correlation coefficients
The coffees noisy data matrix (Yi) was only normalized using the top performing algorithms
identified from the peak recovery criteria. An OPLS-DA model was generated for each normalized
coffees data matrix (Ỹi) and also the original coffees data set (Yo). The datasets were scaled with Pareto
scaling prior to calculating the OPLS-DA models. The first component loadings from each OPLS-DA
model were then used to calculate a Pearson correlation coefficient between the true backscale loadings
vector ( po) from the original coffees data set (Yo) and the backscale loadings vector ( pi ) from each
normalized coffees noisy data matric (Ỹi). The Pearson correlation coefficients were calculated according
to Eq. 4:
∑

𝑟 =
∑

̅ )(

(
̅

∑

̅ )

(4)
̅

where K denotes the number of spectral features; p̄i is the mean loading of vector pi ; pk i is the kth
loading of vector pi ; p̄ 0 is the mean loading of vector p0; and pk 0 is the kth loading of vector p0. This
process was repeated 100 times. The mean correlation coefficients and standard error were calculated for
each normalized set.

3.7 Results and discussion
The two reference NMR spectra displayed in Fig. 1 were used to generate eight noise-added simulated
metabolomics datasets consisting of 25 spectra for each of the two groups (Fig. S1). Accordingly, each
simulated dataset contained a total of 50 spectra. The total signal variance in each dataset was defined by
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the amount of Gaussian noise added and by the dilution factors listed in Table 1. The simulated NMR
metabolomics datasets were then normalized using each of the nine normalization methods (i.e., CS,
CSpline, HM, MSC, PQ, Q, ROI, SNV, and SSpline). A peak recovery was calculated for each dataset
according to Eq. 3. The peak recovery compares each of the normalized dataset to the original reference
NMR spectra (Fig. 1). The peak recoveries for each normalized dataset are plotted in Figs. 2 and 3. As
expected, the efficiency of peak recovery decreases with increasing signal variance regardless of the
normalization method. As illustrated in Fig. 2, most of the normalization methods achieve nearly 100%
peak recovery (96 to 99%) under conditions of modest signal variance (S1 and S2). The most notable
outlier is HM, which achieved a peak recovery of only 20–28%. This extremely poor performance
suggests that HM should be avoided and not used for the normalization of NMR metabolomics data.
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Figure 2. A plot of the recovery of peak intensities (eqn. 3) for the 9 normalization methods after being
applied to the 8 (S1 to S8) simulated datasets listed in Table 1. The total signal variance due to the amount
of added Gaussian noise and the magnitude of the dilution factor increases from S1 to S8. The horizontal
dashed lines represent a full recovery at 100% and partial recovery at 50%. Each bar represents the mean
peak recovery and the error bars represent ±2*standard error of the mean.
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While significantly better than HM, SSpline also performed consistently below average with a
peak recovery range of 93–95%. PQ was modestly below the best performers with a peak recovery range
of 96–97%. Conversely, ROI, CS, SNV, MSC, and Q, recovered at least 98% of the peak intensities
under conditions of modest signal variance. A further separation in algorithm performance was apparent
as the signal variance was progressively increased. SSpline continued to perform worse than average, but
from simulated set S5 forward the performance of SNV had also significantly declined to match SSpline.
Similarly, from simulated set S6, CSpline had fallen below the average performance of the other
normalization methods. In fact, as the amount of signal variance was increased to the highest level (S8),
the peak recoveries for CSpline, HM, MSC, Q, and SSpline all fell below 50%. Conversely, CS, PQ and
ROI maintained a peak recovery of around 70% (67–74%).
Accordingly, the peak recovery results suggest that the CS, PQ and ROI were the most robust
normalization methods and were able to maintain a maximal peak recovery as a function of signal variance
(Fig. 3). Pairwise Student’s t tests of the mean peak recovery values at the highest signal variance level (S8)
yield a maximum p-value of <2.8×10−13 between the CS, PQ, ROI algorithms and the other normalization
methods. To further investigate the individual impact of Gaussian noise and dilution factors on peak
recovery, the simulation was repeated for the three top performing normalization methods (i.e., CS, PQ and
ROI). Instead of simultaneously varying both Gaussian noise and the dilution factors as listed in Table 1,
the simulation was repeated with either Gaussian noise or the dilution factor held
constant at S1 values. The combined average peak recovery values for CS, PQ and ROI normalized
datasets are plotted as a function of added Gaussian noise or dilution factor in Fig. 4. This simulation
yielded an unexpected result. The performance of the normalization method was essentially unaffected by
the dilution factor. Near perfect peak recovery was obtained even for the highest dilution factor. Instead,
the normalization performance was strictly dependent on the level of Gaussian noise added to the spectra.
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Figure 3. A plot of the recovery of peak intensities (eqn. 3) for the three top performing normalization
methods after being applied to the 8 (S1 to S8) simulated datasets listed in Table 1. The total signal variance
due to the amount of added Gaussian noise and the magnitude of the dilution factor increases from S1 to
S8. The horizontal dashed lines represent a full recovery at 100% and partial recovery at 50%. Each bar
represents the mean peak recover and the error bars represent ±2*standard error of the mean.
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However, it is important to note that normalization methods also rely on good peak alignment,
spectral phasing, baseline correction and solvent suppression in order to perform well. Accordingly, the
simulations reported herein were restricted to well-behaved datasets. While being able to accurately
reconstitute peak intensity is an important attribute of a normalization algorithm, the proper identification
of group-defining spectral features is still a vital necessity. In essence, are biologically-relevant metabolic
differences still being correctly identified regardless of the natural signal variance? Does a PCA or OPLS
scores plot yield statistically relevant group separations and do the loadings identify the “true” metabolic
differences between the groups? To address this issue, the CS, PQ and ROI normalization methods were
further evaluated based on the reproducibility of OPLS-DA models as a function of increasing signal
variance. An experimental coffees dataset previously used to investigate PCA and OPLS model stability 26
was employed to generate OPLS-DA models using the CS, PQ and ROI normalization methods.
Specifically, the coffee dataset consists of 32 1D 1 H NMR spectra for two groups of observations (light
and medium decaffeinated coffees). The coffees dataset was modified with Gaussian noise and a dilution
factor (Fig. S2) as outlined in Table 2. Consistent with our prior observations26 the two coffee groups
become indistinguishable with an increase in signal variance. Importantly, the estimated loadings from
the corresponding OPLS-DA model are less correlated to the true loadings (Fig. 5) with increasing signal
variance. Notably, at minimal to moderate signal variance levels (C1 to C3), the PQ and ROI
normalization methods perform almost identically and significantly better than CS. But, as the amount of
signal variance increased significantly (C4 to C7), the OPLS-DA model was no longer valid with the ROI
normalization technique; and the loadings correlation, not surprisingly, decreased dramatically. Similarly,
the standard errors of mean loadings correlation coefficients increased significantly for ROI compared to
the negligible values observed for CS and PQ (ranged from 0.0003 to 0.008). Interestingly, despite CS
initially performing worse than PQ, there was no difference in the loadings correlation between PQ and
CS at C4. Furthermore, CS outperformed PQ at the highest signal variance levels (C5 to C7). But, the
loadings correlations still decreased linearly with increasing signal variance following CS or PQ
normalization. The loss of a correlation to the true loadings was still substantial and would likely lead to
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incorrect biological interpretations. A similar set of results was obtained for the simulated dataset (Fig.
S3). In total, our analysis suggest that CS and PQ are the most robust normalization techniques and are
able to compensate, at least partly, for large signal variance. Both CS and PQ maintained the highest level
of peak recovery and the highest correlation between backscaled loadings. Notably, PQ was the most
robust normalization technique at low to moderate noise levels while CS was slightly better at
compensating for larger signal variance. A combined analysis of the peak recovery and OPLS-DA
backscaled loadings data provides some further guidance for designing and executing an NMR
metabolomics study. As we have noted previously26,30,31, noise is detrimental to the accurate and reliable
analysis of metabolomics data using multivariate statistical techniques such as PCA and OPLS. The
results reported herein further support the negative impact of noise on the analysis of NMR metabolomics
data.
As evident in Fig. 4, a dilution factor had no appreciable impact on the performance of a
normalization method. Instead, all variance in the performance of the normalization methods was due to
noise. Furthermore, most of the normalization methods performed equally-well in regards to peak
recovery and loadings correlation for added noise levels up to about 20%. The lone exception is HM,
which should be avoided. A significant decay in performance occurred when >20% of noise was added to
either the simulated or experimental dataset. Accordingly, an experimental NMR dataset that exhibits
greater than 20% noise is a serious concern and the resulting chemometrics model is highly suspect. In
essence, our analysis sets a minimum criterion for maintaining noise (defined by a standard Gaussian
distribution) at below 20% for a valid metabolomics dataset.

54

Figure 4. A plot of the average peak recovery calculated from the three top-performing normalization
methods (CS, PQ, and ROI). Datasets were regenerated according to the scheme described in Table 1 but
containing only a dilution factor (♦) or the addition of Gaussian noise (■). The dilution factor or added
Gaussian noise was held constant at S1 values when the other parameter was varied. The peak recovery
decreases with additive noise, but is unaffected by dilution factor.
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Figure 5. A plot of the average Pearson correlation coefficients (eqn. 4) calculated by comparing the true
backscaled loadings from the original coffee dataset OPLS-DA model relative to the backscaled loadings
from the CS (♦), PQ (■), and ROI (▲) normalized coffees noisy dataset OPLS-DA model. The amount of
signal variance introduced into the coffees dataset is described in Table 2. The error bars represent
±2*standard error of the mean. Please note that most of the error bars are smaller than the size of the
symbols.
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3.8 Conclusion
The nine normalization methods available in our MVAPACK software package were evaluated
for their ability to compensate for increasing signal variance. The performance of the normalization
techniques were tested on simulated and experimental 1D 1 H NMR datasets with the addition of
Gaussian noise and dilution factors. However, it is important to keep in mind that the Gaussian noise and
dilution factors used in model construction are only an approximation of non-biological variance. At low
to moderate noise levels, all of the normalization methods, except HM, performed well in terms of peak
recovery. Accordingly, HM should be avoided as a normalization technique for NMR. Notably, peak
recovery performance was only dependent on added Gaussian noise, and independent of dilution factor.
At high signal variance, most normalization procedures failed to recover true peak intensities except for
CS, PQ, and ROI. Again, PQ and ROI normalization algorithms performed equally-well and significantly
better than CS at low to moderate noise levels in reproducing the backscaled loadings from an OPLS-DA
model. But, ROI generated statistically invalid OPLS-DA models and poor backscaled loadings
correlations at higherlevels of noise. Interestingly, CS performed slightly better than PQ in reproducing
the backscaled loadings at high noise levels. Thus, our results suggest that CS and PQ perform the best in
regards to maintaining the true signal in noisy datasets. Consistent with our prior observations, groups
become indistinguishable with increasing noise; and correlations to the true loadings are lost. In other
words, an increasing level of additive Gaussian noise masks the true signals in the datasets. Accordingly,
if this noise is not handled properly, it will lead to false conclusions and biologically irrelevant
observations. In this regards, our analysis suggests that, at a minimum, noise needs to remain below 20%
in order for an NMR metabolomics dataset to provide an accurate and biologically-relevant chemometrics
model.
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Chapter 4: The Challenges of Mass Spectrometry in Metabolomics

4.1 Introduction
Metabolomics is an increasingly important avenue of biological research. The ideal goal of metabolomics
is to be able to obtain both accurate and precise measurements on as many metabolites (broadly defined
as the small molecule components of cellular metabolism) as possible within a biological system1–3
Theoretically, any analytical method capable of measuring these cellular components can be
used; fourier transform infrared spectroscopy (FT-IR), nuclear magnetic resonance (NMR), capillary
electrophoresis (CE) and mass spectrometry (MS) have all been successfully employed in metabolomics
investigations, particularly in combination with separation techniques such as gas and liquid
chromatography (GC/LC respectively).However, the vast majority of studies are performed using either
NMR or MS1. This is in large part due to their amenability to a wide range of metabolites (unlike CE,
which performs best on charged species) and one-to-one correspondence between a known metabolite and
an observed spectral signal (in contrast with FT-IR methods, which can often only assign a signal to a
specific chemical moiety within a larger structure, rather than identifying individual metabolites on its
own). Additionally, NMR and MS have spatially resolved signals (especially so when using 2Dimensional NMR or LC-MS), making them much more amenable to the analysis of complex mixtures
than more non-specific methods such as 1D-NMR or Infrared/UV which lack the resolving power to
distinguish individual components as the mixture complexity increases4.
Both NMR and LC-MS offer their own unique advantages. NMR is highly reproducible, with
simple sample preparation and amenability to analytes over a wide range of solvent conditions, as well as
definitive structural characterization. Despite these strengths, NMR still struggles with a low sensitivity
which is a major roadblock that is slowing its wider adoption as an analytical technique for metabolomics.
The lower sensitivity of NMR contrasts with MS, which boasts both high sensitivity and low detection
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limits that can detect more subtle metabolite changes that are “NMR-invisible” due to limited
concentrations. However, the nature of MS detectors (and a reliance on ionization processes) necessarily
restricts analysis to metabolites which can be readily ionized. Additionally, it is known that minor
contaminants are known to reduce ionization efficiency, which negatively impacts the reproducibility of
heterogeneous metabolomics samples. Accordingly, NMR and mass spectrometry are often viewed as
complementary techniques that broaden the coverage and improve the accuracy of metabolomics studies 5.
. Given the inherent biases of NMR towards high abundance metabolites and MS inability to
capture poorly ionizing compounds, each method observes a unique subset of the total metabolites present
in a sample, with little overlap between the two sets. A growing recognition of this reality suggests that
simply performing both methods simultaneously when it is appropriate and feasible to do is the best
approach to cover the largest possible set of metabolites present. The complementarity of NMR and mass
spectrometry has resulted in an expanding number of studies that are routinely using both NMR and MS
to characterize metabolomics samples in this way such that each method can compensate somewhat for
the weaknesses of the other. In order to understand this further, an overview of how each method is
commonly used in metabolomics is presented to illustrate the key differences between NMR and MS and
what considerations need to be made when choosing the most appropriate platform for a given study.
NMR, being one of the most fundamental spectroscopic techniques, is able to simultaneously
identify and quantify a large number of metabolites in the micromolar range. As a measurement method,
it is incredibly straightforward and easily automated making it the ideal platform for high-throughput. An
additional benefit is that it is non-destructive, and samples can be recovered and analyzed further with
other methods. It has been used extensively for biomarker discovery 6,7, as well as determining genetic
function8.The major hurdle of NMR is it’s low sensitivity, which places a practical restriction on the
number of metabolites that can be observed. 9NMR spectra require processes such as zero-filling, fourier
transform, phasing, referencing, alignment, normalization, scaling and binning in order to be analyzed by
common statistical processes such as PCA and OPLS in metabolomics. As a result of all of these
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necessary tools, a number of software packages that offer these functionalities have been developed.
However, each of these tools was designed to address a subset of these tasks extremely well, with little
attention given to the rest of the data processing pipeline.
For example, NMRPipe10 mainly focuses on tools for the processing of raw, spectral acquisition
free induction decays into interpretable spectra while packages such as WavPeak focus mainly on
intelligent peaklist generation from previously processed spectra 11.As a result of this, within the NMR
community it has become common to utilize multiple software packages, with each step of spectral
analysis being performed by the tool best suited to the task. This introduces many potential point of
failure, as not all software developed independently of each other can necessarily be guaranteed to
cooperate with one another and offer redundant capabilities.
To address this need, MVAPACK was developed. MVAPACK 12 offers a complete set of tools for
NMR spectral analysis all the way from initial preprocessing such as fourier transform to statistical
analysis and model validation. As a result, metabolomics analysis in NMR can be performed in a single
platform, which supports full transparency, uses only open-source tools in an intuitive and interactive
scripting environment. MVPACK scripts are also easily documented for future use, allowing analyses to
be repeated at any time or extended to include additional steps.
MS in metabolomics has been actively developed over the previous decades, and has been an
incredibly active area of research. Unlike NMR, its high sensitivity allows it to potentially measure
hundreds of metabolites, including lower concentration compounds that are considered NMR-invisible at
physiologically relevant levels13. MS can be used either as a standalone instrument (direct injection) or
coupled to chromatrography. While direct injection can provide a rapid platform suitable for highthroughput, it suffers from issues of reproducibility that arise from differences in ionization efficiency.
Additionally, chromatography is often used in order to reduce the complexity of a sample, conceptually
breaking down the problem into a series of simpler mixtures, each measured back to back as they elute
from a column. This aids in both reducing spectral overlap due to having a large number of components,
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as well as providing a secondary measurement based on separation time that can be used to assign
particularly ambiguous metabolite signals.The processing needs of MS data are quite unique from that of
NMR, requiring the additional tools to address the non-uniformity of collected data such as gap-filling,
and the need to eliminate redundant information with deisotoping. Another major point of contrast to
NMR is the variety of mass selectors and ionization approaches available, which complicates the ability
to perform data analysis with a single software platform. For this reason, MS data is often analyzed using
vendor provided software that has been designed to work with the instrument they are bundled with. A
reliance on this proprietary software makes the task of standardization much more difficult, and is
especially problematic due to it’s lack of transparency and inability to be upgraded to include additional
tools that might be required by an analyst. In much the same way as NMR, MS also developed a wide
range of open-source software tools, each of which was best designed to suit particular steps of the data
processing pipeline. There are two main approaches to using both NMR and MS in a single, integrated
metabolomics study. The first involves samples being independently acquired, extracted and then
separately analyzed by either NMR or mass spectrometry. The final results are then compared to each
other to search for general consistencies in metabolic alteration that are both present and observable by
each method alone. This method is almost always performed as a collaboration, with two (or more)
research groups each focusing on one instrumental method, due to the amount of domain expertise that is
required to perform a high-quality analysis using either NMR or MS. The advantage of performing an
analysis in this way is that it allows each branch of the study to be performed with the best in-class tools
available, and having domain experts available to ensure that all necessary steps of experimental design,
data collection and statistical analysis are being performed appropriately. This also allows for a
comparison of which metabolites and associated metabolic pathways are seen in each method alone. If the
same metabolites are identified by both methods, their relative concentration ranges can be compared and
used to provide a higher degree of confidence that the metabolite assignment is correct than either method
could do alone. However, this may not always be possible due to the unique subsets of metabolites that
are often obtained by each method. The chief disadvantage of this method is the need for multiple
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investigators to perform the data analysis, often with domain specific processing software. This makes it
nearly impossible for a single investigator to perform such integrated studies, and introduces multiple
points of failure as a result of the large variety of potentially applicable tools.
A less popular, but perhaps more beneficial approach, would be to analyze the two methods
simultaneously, using integrated tools that allow a study to be done in a uniform fashion from sample
preparation through to statistical analysis. A number of tools have been developed for combining NMR
and MS, most notably SUMMIT14. Unfortunately, summit does not as of yet include many of the essential
processing tools required to deal with raw MS data, and instead relies on pre-processing and generation of
peaklists by other programs before it performs it’s own methods of statistical integration.
Despite the demonstrated advantages of using both NMR and MS in combination, there are far
fewer tools for performing these integrated analyses than there are for performing either one alone. As a
result, proper multiblock analyses require the development of in-house programs and statistical methods
that present a significant hurdle to researchers wanting to perform these types of analyses who need not
be demanded to possess knowledge of such disparate fields as statistics, computer programming, linear
algebra and machine learning in addition to the experimental peculiarities of their particular domain. One
example of such integrated studies is multiblock analysis. Briefly, multiblock analysis takes measured
variables from multiple discrete “classes” of measurements and exploits the underlying structure of these
variable groupings to determine both overall sample differences as well as the relative contributions of
these variable classes. When applied to metabolomics, each variable grouping would consist of a set of
measurements arising from a given method (e.g., an NMR group, and LC-MS group, etc.). Multiblock
analysis has a major advantage over single methods of analysis, since it is able to make use of data from
both instrumental techniques simultaneously. This has been shown in at least one paper by Marshall et al.
where the integration of NMR and direct-injection mass spectrometry through multiblock modeling
within MVAPACK was able to generate models with greater predictive ability and resolving power than
models generated from either method alone. While this demonstrated the ability of MVAPACK to
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perform data analyses derived from multiple sources, direct-injection MS derived spectra were treated as
pseudo 1D-NMR spectra, and no functions specific to the realm of MS data processing were utilized.
Herein we present a workflow using MVAPACK, in conjunction with freely available tools and the
Octave programming language, capable of working with LC-MS data. This in combination with our
already reported tools for processing NMR, results in a single software environment capable of robust,
easy to perform analyses independent of instrumental platform, and addresses the need for software that
can perform these integrated analyses that the field demands.
4.2 Methods and Software Design
4.2.1 Software design for MVAPACK LC-MS data processing pipeline.
MVAPACK (http://bionmr.unl.edu/mvapack.php) was originally developed in GNU Octave
version 3.6.0, but the recent Octave upgrade to version 4.2.0 required a complete revision to MVAPACK
to remove deprecated functionality used by the loadnmr(), classes(), and addclasses() functions.
MVAPACK is comprised of a set of individual, independent functions that can be readily interchanged or
combined to form the desired processing pipeline. In this regards, the output of one function becomes the
input for the subsequent function in the data handling process, with entire data workflows being simply
represented as a sequence of brief functions called in the order in which they are to be performed.
MVAPACK currently contains the following broad classes of functions: (i) data input , (ii) instrumentspecific preprocessing, (iii) instrument-agnostic preprocessing, (iv) multivariate modeling and
visualization, and (v) model validation.
An LC-MS dataset requires the following processing steps that differ from the NMR processing
and are not currently available in MVAPACK: (i) functions to import LC-MS data, (ii) visualization
utilities for LC-MS data, (iii) and functions to pre-process LC-MS data. Accordingly, in order to
implement an LC-MS data processing pipeline into MVAPACK the following new functions as outlined
in Figure 4.1 were required: mzxmlinfo.m, which loads and stores sample acquisition parameters,
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sparse_matrix_load.m and a number of internal functions including get_line, get_mz_axis and
get_rt_axis, which load an LC-MS sample into a memory efficient structure for storage and manipulation,
array_converter.m, which removes unnecessary metadata and prepares for statistical analysis, threshold.m
which allows for the generation of peaklists, plotscan.m and plotscan3d.m, which allow for visualization
of imported data.
For file import, a number of vendor formats are commonly available. In order to make this
process as general as possible, an open-source data format was required. Specifically, a common fileformat used to represent mass spectral data is mzXML mzXML, first proposed by the HUPO initiative as
a way to represent MS data, has become an accepted, vendor-independent MS storage format. Briefly,
mzXML is based on extensible markup language (XML) which is used to represent data in a hierarchical
fashion using tags elements and attributes. The large size of LC-MS datasets relative to NMR is a
fundamental challenge that requires data reduction. This was addressed with a combination of sparse
matrices and thresholding to restrict analysis to non-zero values above a user-defined intensity level.
Uninformative spectral regions were then removed, and peaklists generated from binned regions of the
thresholded data, and multivariate analysis performed on the subsequent peaklists.
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Figure 4.1 Outline Of Functions For Processing LC-MS Data In MVAPACK. Newly developed
functions included plotscan.m, plotscan3d.m, threshold.m, get_line.m, get_rt_axis.m, get_mz_axis.m.
mzxmlinfo.m, base64decoder.m, sparse_matrix_load.m, and array_converter.m.
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4.2.2 Standard LC-MS dataset.
A representative dataset (7MIX_STD LC-MS) from the Sashimi Project Data Repository
(http://sashimi.sourceforge.net/repository.html) was used to evaluate the performance of the LC-MS data
handling pipeline implemented into our MVAPACK software (http://bionmr.unl.edu/mvapack.php). The
dataset is centroided. A single spectrum in the dataset contains 7161 retention times with 2,194,813
unique m/z values. A two-dimensional (2D) array of retention times and m/z values would result in a
staggering ~15 billion intensity entries. Thus, a single spectrum would require over 120 Gb of RAM if
each intensity is stored as a double precision floating point value (a requirement for most interactive
languages such as python to ensure values are not artificially truncated). Handling a dataset of this size is
computationally intractable for typical compute configurations. Accordingly, the large 7MIX_STD LCMS dataset presents a fundamental problem with processing LC-MS data that was resolved with our
MVAPACK software.
4.2.3 Preparation of experimental metabolomics samples.
The LC-MS data handling pipeline implemented in MVAPACK was further evaluated using a
typical LC-MS dataset comprised of cell lysates. 10 Replicates each of two unique cellular species (E.
coli MG1655 and Wild Type S. aureus) were grown in a preferred media of Luria-Bertania (LB) and
Tryptic Soy Broth (TSB), respectively. 250 mL of sterile media was inoculated to an initial OD 600 of 0.05
and allowed to incubate at 250 rpm at 37 oC. A portion of the cells were harvested at an OD600 of 0.8 and
separated from the growth medium by centrifugation at 12,000 rpm for 60 seconds and then quenched in
ice-cold methanol. Cell pellets were then stored at -80 oC until further processing. Cell pellets were
extracted with 2 ml aliquots of HPLC-grade methanol while vortexing three times for 30 seconds and
resting in dry ice between rounds. Samples were then centrifuged at 12,000 rpm to pellet the cell debris
and 1 mL of supernatant was removed and dried using a Savant Speed-vac system with a labconco freeze
dryer. Dried extracts were reconstituted in 1 mL of 0.1% formic acid and centrifuged at 10000 rpm for 5
minutes to remove any insoluble material.
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4.2.4 Acquisition of LC-MS spectra.
The LC-MS analyses were performed using an ACQUITY Ultra-Performance Liquid
Chromatography (UPLC) system (Waters, Milford, MA, USA) coupled to a Waters Xevo G2-XS Q-TOF
mass spectrometer (Waters Co., Milford, MA, USA.) with an electrospray ionization (ESI) source. The
column used was an ACQUITY UPLC HSS T3 C18 (1.0 × 50 mm, 1.8 μm, Waters Co., Milford, MA,
USA). Column and autosampler temperature were set to 40 °C and 5 °C respectively, and the flow rate
was set at 95 μL/min. The mobile phase was composed of 0.1% formic acid in water (A1) and 0.1%
formic acid in acetonitrile (B1). Two microliters of sample were injected and separated with a linear
gradient program from 1% to 95% B in 7.30 min. The ESI source was set to positive mode with a scan
range of m/z 50 to 1,200. The voltage of the capillary and cone were set to 3.2 kV and 40 V, respectively.
The gas flow for desolvation and cone was 800 and 50 L/h. The source temperature and desolvation gas
temperature were 120 and 400°C, respectively.
4.2.5 Processing of LC-MS spectra.
Waters “.Raw” vendor-formatted data files were converted to an uncompressed text format and
filtered with a continuous wavelet transform using Proteowizard’s MSConvert tool. Data was imported
with the Data analyses were performed in Octave 4.4.0, using a series of functions developed for this
purpose. All analyses were performed on an Intel Pentium 2.6Ghz with 8Gb of RAM, installed with
Windows 10 and Opensuse “Tumbleweed” rolling release.
4.3 Results and Discussion
4.3.1 MVAPACK upgrade to be GNU Octave complaint
The underlying structure of MVAPACK is as a set of functions that run within the Octave
programming language. This occasionally requires updating functions to remove any references to
deprecated functionality whenever a language undergoes a major update. In this latest update, Octave
changed the behavior of the inbuilt fileread() command, used to import plaintext files into Octave.
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Previously, the fileread command returned a column vector containing each individual character of the
text file in the order that it appeared whereas in 4.0 onwards, it returns a new structure that maintains
spacing, tabs and other formatting information so files can be viewed in the same format they appear in a
regular text editor. Each of the functions that utilized this function for reading information from plaintext
files was updated to get the required information from this new structure using a series of regular
expressions.
4.3.2 LC-MS data Input
A particular challenge of MS instruments is the number of vendor proprietary data formats. It
would not be feasible to develop functions that work with each vendor format, especially when
considering that these functions could cease working entirely if an update to the format is made by the
vendor without prior notice. Using an open source format, such as mzXML, alleviates this issue by
creating a universal starting point that all open-source approaches can use. This approach is supported by
both vendors and the community, with mzXML export supported by all MS vendors. The highly
structured style of mzXML makes it simple to identify the location of desired information, with each
section being clearly delineated with start and end tags that represent what is contained between them.
This is accomplished using the loadmzxml() command, which makes use of built-in fileread() commands
of Octave along with regular expressions that pattern match the desired binary data arrays conforming to
the mzXML specification.
4.3.3Data Size and Dimensionality
One of the major hurdles of dealing with MS data (particularly when coupled with a
chromatographic method), is the sheer number of data points that are obtained. In order to process this
data in an interactive way, the size of the dataset must be compressed or reduced significantly, while
minimizing the effects that this compression will have on the final analysis.
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A potential approach to data reduction is to take advantage of the inherent property of an LC-MS
data, which is data sparsity. Simply, not every pair of m/z values and retention times are necessarily
observed in a given sample. Not every m/z value will be seen in every retention time, and vice versa. A
traditional tabular format of data storage would simply represent these unobserved pairs as zeros. Even
though these values are “zero”, the data point still occupies as much disk space or memory as non-zero
values. In essence, the abundance of zero data points waste precious computational resources. An
alternative route would be to denote only the values which are non-zero, implicating that anything not
stored would be zero. An example of such a storage scheme, herein referred to as a sparse matrix, is
presented in Scheme 1. While this is a modest memory savings of 8 bits in this example, it’s important to
remember that A scales exponentially. The increase in memory or disk allocation occurs regardless of
whether meaningful data is present. Notably, the component vectors only scale with the number of values
that must be stored. This is essential for LC-MS data, since a single column (for example, an observed
m/z value) might only be present at one point in the chromatogram and is most efficiently stored as a set
of positional indices and their associated intensity value. As can be seen in figure 3, the number of nonzero values (denoted as nnz), comprises less than 1% of the total data structure using a typical storage
scheme. Thus, a sparse matrix would lead to a >99% reduction in memory or disk utilization. The exact
memory savings is expected to vary depending on instrument resolution and acquisition parameters.
Nevertheless, a sparse matrix potentially resolves the inherent challenge of manipulating large LC-MS
datasets a computer language such as Octave or MVAPACK. Importantly, a sparse matrix approach may
allow large LC-MS datasets to be processed and manipulated transparently or to be easily ported to
another software environment.
An overview of the functions used for processing LC-MS data is shown in figure 4.1. A diagram
explaining the rationale of a sparse matrix is presented in figure 4.2. The 7MIX_STD LC-MS dataset was
used to demonstrate the application of sparse data matrix. Figure 4.3 illustrates how the LC-MS data is
accessed from a sparse matrix. Each intensity-peak ID pair from the 7MIX_STD LC-MS dataset is
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mapped to its experimentally observed intensity. The peak ID is used instead of a definite m/z value in
order to account for discontinuities between groups and across biological replicates. Conversely, a
traditional “dense” matrix approach assumes that a non-zero intensity is obtained for each m/z value. This
occurs even if the intensity is zero across the entire data set. Instead, a peak ID allows for assigning an
m/z value, or a range of m/z values, to an index. In this regards, each LC-MS peak is correctly represented
in the data matrix even it does not occur at the exact retention time or m/z value for all replicates in the
data set.
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Scheme 1. Sparse Matrix Formulation and Rationale
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Scheme 1.2 A dense representation of a sparse matrix
The dense version of this matrix requires explicit storage of the zero values. When the relative proportion
of zero values is incredibly high, this becomes extremely wasteful. Instead, it can be decomposed into
three component vectors containing the indices and non-zero values only.
I=[1 2 2 3 4] (row indices)

J=[3 1 4 2 4] (column indices)

K=[5 3 2 1 4] (non-zero values)

Figure 4.3 Component Vector Decomposition of A
Example memory savings:
A= 4x4 (16 values) *8 = 128 bits
I=5values*8bits=40 bits
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Figure 4.4 Interactive viewing of the 7MIX_STD LC-MS dataset stored as a sparse array in octave.
Retention times are stored as rows, m/z values stored as columns, and sparsity data is displayed along
with the variable. Each line corresponds to a detected peak, read as
(retention_time_index, mz_index) -> intensity value.
Retention times and m/z values are stored in separate axes vectors such that are indexed using the
indices stored in the sparse array to retrieve the associated m/z and retention times for a given peak.

[4.1]
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4.4 Visualization of LC-MS Data
Figures 4 through 7 demonstrate commonly requested visualizations of LC-MS data. These
MVAPACK functions are useful for the visual confirmation of sample and spectral quality that should be
performed prior to attempting multivariate modeling and statistical analysis. Figure 4 shows a top-down
visualization (or more colloquially, a “dot plot”) of a standard sample from the 7MIX_STD LC-MS data
set retrieved from the Sashimi Project Data Repository. The 7MIX_STD LC-MS data set consists of a 7
protein mix, including rabbit glycogen phosphorylase, e. coli beta galactosidase, bovine serum albumin,
myosin, chicken ovalbumin and bovine serotransferrin The data set was chosen to illustrate the
MVAPACK LC-MS data visualization functions due to the small number of components of high spectral
itensity, as well as being an openly-accessible data set that is commonly used for similar benchmarking in
other LC-MS programs. A threshold of 5x109 was applied to the LC-MS dataset so only peaks with
intensities above this threshold value are observable. This type of visualization is particularly important
for identifying regions of the spectrum that either contains peaks or are devoid of data. For example, the
7MIX_STD LC-MS data set lacks high intensity peaks between scans 4000 and 5000, as seen in figure
4.5.
Figure 4.6 shows an expanded view of the chromatographic time points between 1 and 300. A
single high intensity peak occurs at multiple time points, which are being mapped to different peak ID
values. This is due to the peaks occurring at slightly different m/z values. Thus, the visual display of the
LC-MS data set allowed for the identification of the mass deviation, which can then be easily corrected
through an appropriate choice of binning or other suitable approaches. Furthermore, displaying the LCMS data in this manner allows for a reasonable estimate of the mass deviations across the entire datasets.
The new MVAPACK LC-MS visualization functions also allow for displaying wither a single mass
spectrum or chromatogram. A single mass spectrum from the first time point of a chromatographic run is
shown in figure 4.7. Similarly, the separation efficiency for a given biological sample from the data set
may be assessed by viewing the total ion chromatogram as shown in figure 4.8. Importantly, the total ion
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chromatogram and may be statistically analyzed like the mass spectral data using the same set of tools
implemented into MVAPACK.

Figure 4.5 2D Visualization of 7MIX-STD LC-MS data set. Peaks below the given threshold (5x10 9) are
excluded.
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Scan Number

Peak ID

Figure 4.6. Selected region of figure 4 from the first 300 obtained chromatrographic time points. Distinct
peaks can be identified and scan variability can be visually estimated in the “peak ID” axis, which
consists of m/z values with any observed variance out to 0.000001 m/z. Visual estimates can be used to
determine whether a given peak selection and binning routine is applicable to the imported dataset.
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Figure 4.7. Visualization of a single mass spectrum from the LC-MS dataset obtained from E. coli cell
lysates using the plostcan() function. This can be used to visually estimate an acceptable thresholding
intensity and estimate noise levels; this spectrum for example, should have a threshold set no higher than
5000 and no less than 100-200 in order to include sufficient peaks while removing uninformative noise
regions.
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Figure 4.8 Total ion chromatogram (m/z projection) from the LC-MS dataset obtained from E. coli cell
lysates. Generated by summation of m/z intensities within a given scan/chromatrographic time point aand
plotted with the plotscan() function. Can be used to inspect the separation efficiency of the LC portion of
an LC-MS sample acquisition, and determine regions of potential statistical relevance.
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4.5 A Multivariate analyses of LC-MS data
Besides visualization utilities, these samples can also be processed to generate multivariate
statistical models. Samples LC-MS spectra from the E. coli and S. aureus cell lysates were used as a test
dataset to demonstrate the LC-MS data processing pipeline implemented into MVAPACK., The LC-MS
spectra were collected in continuous mode, and processed using the proteowizard MSConvert 15 tool to
convert them into a plantext, mzXML format. The E. coli-S. aureus LC-MS data set was then imported
into MVAPACK using the new loadmzxml() function, and stored as cell arrays of m/z and intensity pairs.
These cell arrays were then transformed into sparse arrays using the array_converter() function, and
subsequently visualized with the plotscan and plotscan3d commands. An appropriate threshold was set
based on the visually determined noise level from these plots, and peaklists generated by this thresholding
were stored in a data matrix used for further statistical modeling. A principal component analysis (PCA)
was generated from the total ion chromatograms for the E. coli-S. aureus LC-MS data set. The entire set
of replicates and full resolution data was utilized for the PCA model. The total Ion Chromatogram was
not subjected to any binning or other processing other than an SNV scaling prior to this PCA analysis.
Using the total ion chromatograms allows for a global visualization of the dataset, with a focus on the
separation efficiency and the identification of potentially discriminative regions in the chromatogram that
can guide subsequent analysis of mass spectra occurring in these regions.
As expected, E. coli and S. aureus form separate and distinct clusters in the PCA scores plot.
Thus, the total ion chromatograms alone are sufficient to distinguish E. coli from S. aureus. The PCA
component weights were projected back onto the original chromatograms to generate a back-scaled
loadings plot to identify the key chromatographic features that define the group separations (Figure 4.10).
The back-scaled loadings show that the strongest contributing factors to group separation are located in
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the retention time region corresponding to 7.6 to 7.8 minutes. This chromatographic region alone is
sufficient to distinguish different between the two bacterial strains. Furthermore, the group dependent
chromatographic region may be used as a tool for variable selection of the mass spectral data.
Using the previous analysis indicating the importance of the retention time range of 7.6 to 7.8
minutes, the analysis of the mass spectral data was restricted to the m/z values occurring at a retention
time of 7.7 minutes. A PCA model was generated from a subset of the E. coli-S. aureus LC-MS data set
corresponding to a retention time of 7.7 minutes. The PCA scores plot and the back-scaled loadings are
shown in figures 4.11 and 4.12. Once again, E. coli and S. aureus form separate and distinct clusters in
the PCA scores plot, but the relative separation is reduced compared to the previous example. This is to
be expected since less data was available to construct the PCA model. In effect, a single mass spectrum
was used for each replicate, which contains significantly less data points than the corresponding
chromatogram. However, the back-scaled loadings based on the mass spectral data are more informative
then the results with the total ion chromatogram. Specifically, the pseudo-mass spectrum allows for the
ready identification of key metabolites that differentiate the two groups. For example, the large, negative
weighting at m/z 227.868 indicates that this metabolite significantly contributes to the observed difference
between the two bacterial strains. Additionally, the observed mass can be combined with the retention
time of 7.7 minutes to assist in assigning a metabolite to the spectral feature.
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Figure 4.9. PCA scores plot generated from the total ion chromatograms from the LC-MS datasets
obtained from E. coli and S. aureus cell lysates. A 4 component PCA model was obtained with a
cumulative R2 of 0.988.
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Figure 4.10. A backscaled loadings plot based on the weights obtained from the model in figure 9. A
strong downregulation in the region around 7.6-7.8 is clearly evident in the first two components of the
model, suggesting the presence of underlying spectral differences in this range.
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Figure 4.11. PCA scores plot generated from the mass spectral data (7.6-7.8 region) obtained from E coli
and S. aureus cell lysates. A four component model was obtained with a cumulative R2 of 0.968.
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?

Figure 4.12. A backscaled loadings plot based on the weights obtained from the model in figure 10. It can
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4.6 Conclusion
Sparse matrices were successfully employed to reduce the effective size of LC- MS data without
any appreciable loss of data quality or information. Sparse matrices were key to the implementation of an
LC-MS data processing pipeline within our MVAPACK metabolomics toolkit. Importantly, the data
processing utilizes the entire LC-MS dataset, which is an important advancement over traditional
approaches that rely on thresholding, or peak picking to reduce the size of the data matrix. These simple
data reduction methods result in a dramatic reduction in size of the entire LC-MS dataset, allowing it to
be processed in an interactive way with the hardware available on a typical user PC. A total of 10 new
functions have been added to MVAPACK that enable inputting, visualization, and processing, of LC-MS.
Thus, MVAPACK can now uniquely process both NMR and mass spectral data and generate a variety of
multivariate models. Importantly, the NMR and mass spectral data can be integrated into a single
statistical model using multi-block (MB) models (i.e., MB-PCA, MB-PLS, and MB-OPLS). MVAPACK
has been developed using GNU Octave, which offers a unique level of customizability that enables a
robust and flexible combination of functions that differs dramatically from of online “black-box”
processing utilities. MVAPACK is open-source software with a simple syntax that can be easily modified
and extended to include additional functions as the metabolomics field continues to evolve.
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Chapter 5. Conclusion
5.1 Future Directions for Data Processing
The field of metabolomics, particularly with respect to data processing, is still in its formative
years. While a variety of chemometric tools have been used to interrogate large metabolomics datasets,
there are still algorithms, such as Random Forest (RF)1 and Support Vector Machines (SVM)2, that have
seen limited utilization. This is primarily due to the paucity of software tools available to the scientific
community. The same lack of adequate software packages plagues many areas of metabolomics, and the
development of software is crucial to advancing the field by evaluating an algorithms utility as well as
uniting the experimental results from multiple instrumental methods. New analytical methods such as
dynamic nuclear polarization for NMR and ion mobility for MS, along with other instrumental
advancements yet to be made, offer new avenues for exploring and investigating the metabolome.
The pre-processing of NMR data, as outlined in chapter 3, has a delicate interplay with the results
of statistical modeling. It requires experience in statistics in order to evaluate the proper choices, and how
properties inherent to the dataset being considered can completely obfuscate the true underlying factors
when employed with poor judgement. Making the community aware of these pitfalls, not only with the
process of normalization but will all processing routines, will hopefully generate greater awareness of
their importance and generate more comparative assessments and discussion of similar pitfalls in other
user-defined approaches such as binning and peak selection in NMR and deisotoping and gap-filling in
MS in the context of metabolomics.
LC-MS has cemented itself as a requisite method for performing metabolomics and other
chemometric investigations. However, with the growing awareness of the synergistic information
contained from both NMR and LC-MS, it is likely that other instrumental methods such as CE and FT-IR
will see increased use as well. As the number of instruments that can be used rises, the need for a single
data analysis platform becomes increasingly apparent in order to unify the characteristic metabolic
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signatures that each method is uniquely capable of observing. The ability to process LC-MS data in
MVAPACK, in combination with its demonstrated utility for NMR data, represents a fundamental
advance in multi-platform metabolic investigations. Utilizing open-source software allows the user to
observe the underlying statistical processes, allowing reasearchers to ensure that algorithms are being
appropriately applied to their dataset in question. MVAPACK eliminates the “black-box” approach to
data analysis and opens the way for investigators to develop their own methods to analyze and interpret
their data in whichever ways demonstrate themselves to be best-suited to the task. The methods outlined
in this thesis as well as those yet to be developed, not only need to be further refined, but a particular
emphasis on their distribution into simple software packages is crucial to their wider adoption by the
scientific community. The principal burden halting researchers from performing more advanced analyses
is simply not having these tools freely available, verified to work together and with clear instructions on
their proper use. An excellent example is multiway analysis, which currently is only being performed
routinely be a few research groups, and is almost exclusively restricted to commercial users of
MATLAB3. Additional examples include other multivariate analysis approaches that have significant
followings in other fields, but are largely unproven in the metabolomics community such as the random
forest4 whose applicability to this field will become more apparent once they become available in
standardized platforms such as MVAPACK. It is speculated again that this is largely the result of them
not being included as options in most software that has been distributed in the metabolomics community
to date, and their implementation is not straightforward. The turning point will be when such algorithms
are freely shared between all disciplines, and becomes just as simple to apply to metabolomic data as the
methods of OPLS and PCA which are already commonplace. Getting to this point will require ongoing
effort from chemists, statisticians and computer scientists to ensure that processes are simple, welldocumented and evolving to meet the new challenges we encounter.
Lastly, a trend of simply adding another dimension to our instrumentation (2/3-dimensional NMR
or LC-LC-MS for example) has become accepted as a method of dealing with the complexity of

92
biologically derived datasets that metabolomics concerns itself with. While this is fine for univariate
studies where resolution of a single, known metabolite can be targeted with a high degree of confidence,
it only magnifies the issues of data size that were presented in chapter 4. Additionally, it especially
complicates analysis due to the exponential increase in data size on complex samples; the unknown
composition of metabolomics samples often means that biological insight cannot be used to remove
regions of uninformative data. Great strides in chemometrics are being made in the area of multiway
analysis3,5–7, which concerns itself with developing variants of modeling algorithms suitable for high
dimensional data. While their utility in application-driven metabolomics is still largely undemonstrated,
this may present another promising avenue of research and quantify changes arising from multiple
instrumental techniques.
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Appendix of New MVAPACK Functions
Function 1. loadmzxml.m
function [mz,intensity] = loadmzxml(filename)
%Lines of this form are comments to the reader for clarity
file_as_string = fileread(filename);
[ax,bx,cx,dx,ex,fx,gx] = regexp(file_as_string, 'cvParam: m/z array, m/z\s+binary:\s\[\d+\]\s[\d\.\s]+');
[ay,by,cy,dy,ey,fy,gy] = regexp(file_as_string, 'cvParam: intensity array, number of detector
counts\s+binary:\s\[\d+\]\s[\d\.\s]+');
x=dx;
y=dy;
%Remove extraneous header information
[a,b,c,d,e,f,x_stripped] =regexp(x, 'cvParam: m/z array, m/z\s+binary: \[\d+\]');
[a,b,c,d,e,f,y_stripped] =regexp(y, 'cvParam: intensity array, number of detector counts\s+binary: \[\d+\]');
x=cell
y=cell
%Unpack data from hierarchy.
for i = 1:length(x_stripped)
temp=x_stripped{i};
x_unpacked=temp{2};
x_trim=strtrim(x_unpacked);
x_split=strsplit(x_trim);
%results in a cell array of m/z values for each scan.
mz{i}=x_split;
endfor
%Now for the intensities.
for i = 1:length(y_stripped)
temp=y_stripped{i};
y_unpacked=temp{2};
y_trim=strtrim(y_unpacked);
y_split=strsplit(y_trim);
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%results in a cell array of intensity values for each scan.
intensity{i}=y_split;
endfor
endfunction

Function 2. Plotscan.m
function [imputed] =plotscan(mz_axis, mz_array, intensities, scan_number)
if (nargin != 4)
print_usage();
endif

imputed=zeros(size(mz_axis));
for i = 1:length(mz_array{scan_number})
peak=str2num(mz_array{scan_number}{i});
idx=lookup(mz_axis,peak);
imputed(idx)=str2num(intensities{scan_number}{i});
endfor

#Progress Display
%printf('Size of mz axis %d \n', size(mz_axis));
%printf('Size of imputed %d \n', size(imputed));
%fflush(stdout);
plot(mz_axis, imputed);
endfunction
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Function 3. Plotscan3d.m
function [] = plotscan3D(x,y,scan_number)
#This function will use data stored in cell arrays.

#m/z values (x axis)
mz =str2double(x{scan_number});

#intensity values (y axis)
intensity = str2double(y{scan_number});
#Plot the newly formatted results.
plot(mz, intensity);
endfunction

Function 4. Threshold.m
function [features,level] = threshold(x,level)
% check for proper arguments.
if (!any(nargin == [1 : 2]) || !any(nargout == [1 : 2]))
% improper arguments. print the usage statement.
print_usage();
end

% see if a threshold value was provided.
if (nargin < 2 || isempty(level) || !isscalar(level))
%No thresholding value provided. Print usage.
print_usage();
end

%Decompose sparse matrix into component vectors
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[rt,mz,int]=find(x);

%modify the intensity values in-situ
int(int<level)=0;

%Generate New Sparse matrix
features=sparse(rt,mz,int);
end

Function 5. Get_axes.m
function [mz_axis, rt_axis]=get_axes(mz_array, filename)

#Step 0: Load in the file
file_as_string = fileread(filename);

%Build the m/z axis
%Pull the data out the nested cell arrays
mz_cell=cell2mat(mz_array);
mz_axis=cell2mat(mz_cell);

#Sort the m/z values and remove duplicates
mz_axis=unique(mz_axis);

#Now let's get the rt axis.
#refer to the loadmzxml function for a quick example of extracting RT's.
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[~,~,~,rt_instances,~,~,~]=regexp(file_as_string, 'cvParam: scan start time, [\d]+[\.,][\s\d]+[\s\S]');
[~,~,~,rt_axis,~,~,~]=regexp(rt_instances, '[\d\.]+');

for i= 1:length(rt_axis)
rt_axis{i}{1}=str2num(rt_axis{i}{1});
printf("Processing Retention Time: %d \n", i);
fflush(stdout);
endfor
#Build the axis
rt_axis=cell2mat(rt_axis);
rt_axis=cell2mat(rt_axis);

endfunction

Function 6. Mzxmlinfo.m

function [info]= mzxmlinfo(filename)

%Garbage Test Function
%function [elem,data,att,StartTime] = mzxmlinfo

%Add path to xerces parsing files
javaaddpath('/path/to/xerces /xercesImpl.jar');
javaaddpath('/path/to/xerces/xml-apis.jar');
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%Emulates behavior of xmlread in matlab
parser = javaObject('org.apache.xerces.parsers.DOMParser');
parser.parse(filename);
xDoc = parser.getDocument;

%Examples of Xerces Use
%elem = xDoc.getElementsByTagName('precursorMz').item(0);
%data = elem.getFirstChild.getTextContent;
%att = elem.getAttribute('precursorIntensity');

%FileSize
[file_info, err, msg] = stat(filename);
filesize = file_info.size;

%Number of Scans;stored in NumScans
msRun = xDoc.getElementsByTagName('msRun').item(0);
NumScans = msRun.getAttribute('scanCount');
%if NumScans not empty
%return NumScans
%else (IE, if empty)
%return "Not given; check the file."
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%Start Time of Run
msRunStart = xDoc.getElementsByTagName('msRun').item(0);
StartTime = msRunStart.getAttribute('startTime');

%End Time of Run
msRunEnd = xDoc.getElementsByTagName('msRun').item(0);
EndTime = msRunEnd.getAttribute('endTime');

%Data Pre-processing Information

%Is it centroided?
centroid = xDoc.getElementsByTagName('dataProcessing').item(0);
centroided = centroid.getAttribute('centroided');
if centroided == "1"
centroided = "Yes";
else
centroided = "N/A";
endif
%Note, if centroid is ==1, the data has been previously centroided.

%Is it deisotoped?
deisotope = xDoc.getElementsByTagName('dataProcessing').item(0);
deisotoped = deisotope.getAttribute('deisotoped');
if deisotoped == "1"
deisotoped = "Yes";
else
deisotoped = "N/A";
endif
%Note, if deisotoped is ==1, the data has been previously centroided.

101

%Is it charge deconvoluted?
chargeDeconvo = xDoc.getElementsByTagName('dataProcessing').item(0);
chargeDeconvoluted = chargeDeconvo.getAttribute('chargeDeconvoluted');
if chargeDeconvoluted == "1"
chargeDeconvoluted = "Yes";
else
chargeDeconvoluted = "N/A";
endif

%Note, if chargeDeconvoluted is ==1, the data has been previously centroided.

%Spot-Integrated?
spotInt = xDoc.getElementsByTagName('dataProcessing').item(0);
spotIntegrated = spotInt.getAttribute('spotIntegrated');
if spotIntegrated =="1"
spotIntegrated = "Yes";
else
spotIntegrated = "N/A";
endif
%Note, if spotIntegrated is ==1, the data has been previously centroided.

%Tandem?
elem = xDoc.getElementsByTagName('dataProcessing').item(0);
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info = struct("Filename", filename, "Filesize", filesize, "Number of Scans", NumScans, "Start Time",
StartTime, "End Time", EndTime, "Centroided?", centroided, "Deisotoped?", deisotoped, "Charge
Deconvoluted?",
chargeDeconvoluted, "Spot Integrated?", spotIntegrated);
endfunction

Function 7. Sparse_matrix_load.m
function [mz_list,intensity_list,info] = sparse_matrix_load(filenames,verbose)
if (!nargin == 1:2 || !nargout == 2:3)
print_usage();
endif

%Check if single or multiple files are presented
if (ischar(filenames))
filenames={filenames};
elseif (iscellstr(filenames))
if (length(filenames) == 0)
%Error. Warn user.
error('sparse_load: zero files supplied. Check your filenames array');
endif
endif

%Initialize a structure to store the data
data_struct=struct();
data_struct.files=filenames;
data_struct.sample=cell(size(data_struct.files));
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%Load the file and begin munging.

for i=1:length(filenames)

file_as_string = fileread(filenames{i});
#check for version incompatibilities with fileread()
v=version;
if ((v="3.6.2"))
file_as_string = rot90(file_as_string);
endif
%Match the scans
[~,~,~,rt_instances,~,~,text_splits]=regexp(file_as_string, 'cvParam: scan start time,
[\d]+[\.,][\s\d]+[\s\S]');

%Get the mz values
[~,~,~,mz_splits,~,~,~] = regexp(text_splits, 'cvParam: m/z array, m/z\s+binary:\s\[\d+\]\s[\d\.\s]+');
[~,~,~,~,~,~,mz_stripped]= regexp(mz_splits, 'cvParam: m/z array, m/z\s+binary: \[\d+\]');
%Partitioning the mz values
mz_list={};
for i= 2:length(mz_stripped)
temp =mz_stripped{i};
if (length(temp)==2)
mz_unpacked=temp{2};
mz_trim=strtrim(mz_unpacked);
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mz_split=strsplit(mz_trim, ' ');
mz_list{(i-1)}=mz_split;% (i-1) since first entry will always be non-pertinent metadata
else
mz_list{(i-1)}={};
endif
endfor

%Get the intensity values
[~,~,~,intensity_splits,~,~,~] = regexp(text_splits, 'cvParam: intensity array, number of detector
counts\s+binary:\s\[\d+\]\s[\d\.\s]+');
[~,~,~,~,~,~,int_stripped] =regexp(intensity_splits, 'cvParam: intensity array, number of detector
counts\s+binary: \[\d+\]');
%Partitioning the intensity values
intensity_list={};
for i= 2:length(int_stripped)
temp =int_stripped{i};
if (length(temp)==2)
int_unpacked=temp{2};
int_trim=strtrim(int_unpacked);
int_split=strsplit(int_trim, ' ');
intensity_list{(i-1)}=int_split; %First entry is metadata
else
intensity_list{(i-1)}={};
endif
endfor

endfor
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%Generate the retention time and m/z axes.
%Match the scans first.
[~,~,~,rt_instances,~,~,text_splits]=regexp(file_as_string, 'cvParam: scan start time,
[\d]+[\.,][\s\d,]+[\s]+second');
%NOTE this regex pattern is different (and more correct) than the one used in the loadmzxml function.
%Still cant figure out how to extract the actual units (assuming seconds?) from the file itself.
endfunction

%Determine whether to display function progress
#{
if (verbose="True")
scan=0
for i=1:
printf("Processing Scan #: %d \n", scan);
fflush(stdout);
sleep(1); (not required since for loop itself takes comp time)
scan++;
endfor
endif
#}

#{
%Sample Metadata and Information Extraction
%Empty Scan Information
empty_scans=[];
for i = 1:length(mz)
if length(mz{i})==0
empty_scans(end+1)=i;
endif
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endfor

info.text=sprintf("This sample contains %d empty scans", length(empty_scans));
info.empty_scans=empty_scans;

#}
endfunction

Function 8. Array_converter.m

function [numeric_data_array]=array_converter(string_data_array)

string_data_array=strsplit(string_data_array);
string_array=string_data_array(4:end-1);
numeric_data_array=cellfun(@str2num,string_array);

endfunction
_____________________________________________________________________________________
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Function 9. Loader_function.m
#Load the text strings corresponding to the m/z and int values into octave.
#Load the datafile
name='insertfilenamehere.txt';
file=fopen(name);

####2. Iterates and constructs the data array
#Note, file should already be MSConvert output and CWT filter applied.####
#init values
data={};
i=1;
#start loop
while(!feof(file))
string=fgetl(file);
data{i}=string;
i++; #leave out semicolon if you want to monitor progress.
printf("Processing Line#: %d\n",i);
fflush(stdout);
endwhile
endfunction

